TCGA Workflow: Analyze cancer genomics and epigenomics data using Bioconductor packages
TCGA Workflow: Analyze cancer genomics and epigenomics data using Bioconductor packages
- 1 About
- 2 Abstract
- 3 Introduction
- 4 Methods
- 5 Conclusion
- Author contributions
- Competing interests
- Grant information
- Acknowledgements
- References
1 About
This workflow is based on the article: TCGA Workflow: Analyze cancer genomics and epigenomics data using Bioconductor packages (Silva et al. 2016). Due to time and space contraints we downloaded only a subset of the data, for a real analysis please use all data available. The data used in the examples are available in the package TCGAWorkflowData.
1.1 Installation
To be able to execute all the steps of this workflow please install it with the following code:
source("https://bioconductor.org/biocLite.R")
deps <- c("pathview", "clusterProfiler", "ELMER", "DO.db","GO.db",
"ComplexHeatmap", "EDASeq", "TCGAbiolinks", "AnnotationHub",
"gaia","ChIPseeker", "minet","BSgenome.Hsapiens.UCSC.hg19",
"MotifDb", "MotIV", "rGADEM", "motifStack", "RTCGAToolbox")
for(pkg in deps) if (!pkg %in% installed.packages()) biocLite(pkg, dependencies = TRUE)
deps <- c("devtools","DT","pbapply","readr","circlize")
for(pkg in deps) if (!pkg %in% installed.packages()) install.packages(pkg,dependencies = TRUE)
devtools::install_github("BioinformaticsFMRP/TCGAWorkflowData")
devtools::install_github("BioinformaticsFMRP/TCGAWorkflow", dependencies = TRUE)1.2 Loading packages
At the beginning of each section, the packages required to execute the code will be loaded. However the following packages are required for all sections.
- TCGAWorkflowData: this package contains the data necessary to execute each of the analysis steps. This is a subset of the downloaded to make the example faster. For a real analysis, please use all the data available.
- DT: we will use it to visualize the results
library(TCGAWorkflowData)
library(DT)2 Abstract
Biotechnological advances in sequencing have led to an explosion of publicly available data via large international consortia such as The Cancer Genome Atlas (TCGA), The Encyclopedia of DNA Elements (ENCODE), and The NIH Roadmap Epigenomics Mapping Consortium (Roadmap). These projects have provided unprecedented opportunities to interrogate the epigenome of cultured cancer cell lines as well as normal and tumor tissues with high genomic resolution. The Bioconductor project offers more than 1,000 open-source software and statistical packages to analyze high-throughput genomic data. However, most packages are designed for specific data types (e.g. expression, epigenetics, genomics) and there is no one comprehensive tool that provides a complete integrative analysis of the resources and data provided by all three public projects. A need to create an integration of these different analyses was recently proposed. In this workflow, we provide a series of biologically focused integrative analyses of different molecular data. We describe how to download, process and prepare TCGA data and by harnessing several key Bioconductor packages, we describe how to extract biologically meaningful genomic and epigenomic data. Using Roadmap and ENCODE data, we provide a work plan to identify biologically relevant functional epigenomic elements associated with cancer.
To illustrate our workflow, we analyzed two types of brain tumors: low-grade glioma (LGG) versus high-grade glioma (glioblastoma multiform or GBM).
All the package landing pages used in this workflow can be found through the biocViews interface.
Keywords: Epigenomics, Genomics, Cancer, non-coding, TCGA, ENCODE, Roadmap, Bioinformatics.
3 Introduction
Cancer is a complex genetic disease spanning multiple molecular events such as point mutations, structural variations, translocations and activation of epigenetic and transcriptional signatures and networks. The effects of these events take place at different spatial and temporal scales with interlayer communications and feedback mechanisms creating a highly complex dynamic system. To gain insight into the biology of tumours most of the research in cancer genomics is aimed at the integration of the observations at multiple molecular scales and the analysis of their interplay. Even if many tumors share similar recurrent genomic events, their relationships with the observed phenotype are often not understood. For example, although we know that the majority of the most aggressive form of brain tumours such as glioma harbour the mutation of a single gene (IDH), the mechanistic explanation of the activation of its characteristic epigenetic and transcriptional signatures are still far to be well characterized. Moreover, network-based strategies have recently emerged as an effective framework for the discovery functional disease drivers that act as main regulators of cancer phenotypes. Here we describe a comprehensice workflow that integrates many Bioconductor packages in order to analyze and integrate the molteplicity of molecular observation layers in large scale cancer dataset.
Indeed, recent technological developments allowed the deposition of large amounts of genomic and epigenomic data, such as gene expression, DNA methylation, and genomic localization of transcription factors, into freely available public international consortia like The Cancer Genome Atlas (TCGA), The Encyclopedia of DNA Elements (ENCODE), and The NIH Roadmap Epigenomics Mapping Consortium (Roadmap) (Hawkins, Hon, and Ren 2010). An overview of the three consortia is described below:
The Cancer Genome Atlas (TCGA): The TCGA consortium, which is a National Institute of Health (NIH) initiative, makes publicly available molecular and clinical information for more than 30 types of human cancers including exome (variant analysis), single nucleotide polymorphism (SNP), DNA methylation, transcriptome (mRNA), microRNA (miRNA) and proteome . Sample types available at TCGA are: primary solid tumors, recurrent solid tumors, blood derived normal and tumor, metastatic, and solid tissue normal (Weinstein et al. 2013).
The Encyclopedia of DNA Elements (ENCODE): Found in 2003 by the National Human Genome Research Institute (NHGRI), the project aims to build a comprehensive list of functional elements that have an active role in the genome, including regulatory elements that govern gene expression. Biosamples includes immortalized cell lines, tissues, primary cells and stem cells (Consortium and others 2011).
The NIH Roadmap Epigenomics Mapping Consortium: This was launched with the goal of producing a public resource of human epigenomic data in order to analyze biology and disease-oriented research. Roadmap maps DNA methylation, histone modifications, chromatin accessibility, and small RNA transcripts in stem cells and primary ex vivo tissues (Fingerman et al. 2011; Bernstein et al. 2010).
Briefly, these three consortia provide large scale epigenomic data onto a variety of microarrays and next-generation sequencing (NGS) platforms. Each consortium encompasses specific types of biological information on specific type of tissue or cell and when analyzed together, it provides an invaluable opportunity for research laboratories to better understand the developmental progression of normal cells to cancer state at the molecular level and importantly, correlate these phenotypes with tissue of origins.
Although there exists a wealth of possibilities (Kannan et al. 2015) in accessing cancer associated data, Bioconductor represent the most comprehensive set of open source, updated and integrated professional tools for the statistical analysis of large scale genomic data. Thus, we propose our workflow within Bioconductor to describe how to download, process, analyze and integrate cancer data to understand specific cancer-related specific questions. However, there is no tool that solves the issue of integration in a comprehensive sequence and mutation information, epigenomic state and gene expression within the context of gene regulatory networks to identify oncogenic drivers and characterize altered pathways during cancer progression. Therefore, our workflow presents several Bioconductor packages to work with genomic and epigenomics data.
4 Methods
4.1 Access to the data
TCGA data is accessible via the the NCI Genomic Data Commons (GDC) data portal, GDC Legacy Archive and the Broad Institute’s GDAC Firehose. The GDC Data Portal provides access to the subset of TCGA data that has been harmonized against GRCh38 (hg38) using GDC Bioinformatics Pipelines which provides methods to the standardization of biospecimen and clinical data, the re-alignment of DNA and RNA sequence data against a common reference genome build GRCh38, and the generation of derived data. Whereas the GDC Legacy Archive provides access to an unmodified copy of data that was previously stored in CGHub(Wilks et al. 2014) and in the TCGA Data Portal hosted by the TCGA Data Coordinating Center (DCC), in which uses as references GRCh37 (hg19) and GRCh36 (hg18).
The previously stored data in CGHub, TCGA Data Portal and Broad Institute’s GDAC Firehose, were provided as different levels or tiers that were defined in terms of a specific combination of both processing level (raw, normalized, integrated) and access level (controlled or open access). Level 1 indicated raw and controlled data, level 2 indicated processed and controlled data, level 3 indicated Segmented or Interpreted Data and open access and level 4 indicated region of interest and open access data. While the TCGA data portal provided level 1 to 3 data, Firehose only provides level 3 and 4. An explanation of the different levels can be found at TCGA Wiki. However, the GDC data portal no longer uses this based classification model in levels. Instead a new data model was created, its documentation can be found in GDC documentation. In this new model, data can be open or controlled access. While the GDC open access data does not require authentication or authorization to access it and generally includes high level genomic data that is not individually identifiable, as well as most clinical and all biospecimen data elements, the GDC controlled access data requires dbGaP authorization and eRA Commons authentication and generally includes individually identifiable data such as low level genomic sequencing data, germline variants, SNP6 genotype data, and certain clinical data elements. The process to obtain access to controlled data is found in GDC web site.
Finally, the data provided by GDC data portal and GDC Legacy Archive can be accessed using Bioconductor package TCGAbiolinks, while the data provided by Firehose can be accessed by Bioconductor package RTCGAToolbox.
The next steps describes how one could use TCGAbiolinks & RTCGAToolbox to download clinical, genomics, transcriptomics, epigenomics data, as well as subtype information and GISTIC results (i.e., identified genes targeted by somatic copy-number alterations (SCNAs) that drive cancer growth). All the data used in this workflow has as reference the Genome Reference Consortium human genome (build 37 - hg19).
4.1.1 Downloading data from TCGA data portal
The Bioconductor package TCGAbiolinks (Colaprico et al. 2016) has three main functions GDCquery, GDCdownload and GDCprepare that should sequentially be used to respectively search, download and load the data as an R object.
GDCquery uses GDC API to search the data for a given project and data category and filters the results by samples, sample type, file type and others features if requested by the user. This function returns a object with a summary table with the results found (samples, files and other useful information) and the arguments used in the query. The most important GDCquery arguments are project which receives a GDC project (TCGA-USC, TCGA-LGG, TARGET-AML, etc), data.category which receives a data category (Transcriptome Profiling, Copy Number Variation, DNA methylation, Gene expression, etc), data.type which receives a data type (Gene expression quantification, Isoform Expression Quantification, miRNA Expression Quantification, Copy Number Segment, Masked Copy Number Segment, etc), workflow.type, which receives a GDC workflow type (HTSeq - Counts, HTSeq - FPKM-UQ, HTSeq - FPKM), legacy, which selects to use the legacy database or the harmonized database, file.type, which receives a file type for the searches in the legacy database (hg18.seg, hg19.seg, nocnv_,hg18.seg, nocnv_hg19.seg, rsem.genes.results, rsem.genes.normalized_results, etc) and platform, which receives a the platform for the searches in the legacy database (HumanMethylation27, Genome_Wide_SNP_6, IlluminaHiSeq_RNASeqV2, etc). A complete list of possible entries for arguments can be found in the TCGAbiolinks vignette. Listing 1 shows an example of this function.
After the search step, the user will be able to download the data using the GDCdownload function which can use either the GDC API to download the samples, or the gdc client tools. The downloaded data will be saved in a directory with the project name and a sub-folder with the data.category, for example “TCGA-GBM/DNA_methylation”.
Finally, GDCprepare transforms the downloaded data into a summarizedExperiment object (Huber et al. 2015) or a data frame. If SummarizedExperiment is set to TRUE, TCGAbiolinks will add to the object sub-type information, which was defined by The Cancer Genome Atlas (TCGA) Research Network reports (the full list of papers can be seen in TCGAquery_subtype section in TCGAbiolinks vignette), and clinical information. Listing 1 shows how to use these functions to download DNA methylation and gene expression data from the GDC legacy database and 2 shows how to download copy number variation from harmonized data portal. Other examples, that access the harmonized data can be found in the TCGAbiolinks vignette.
library(TCGAbiolinks)
# Obs: The data in the legacy database has been aligned to hg19
query.met.gbm <- GDCquery(project = "TCGA-GBM",
legacy = TRUE,
data.category = "DNA methylation",
platform = "Illumina Human Methylation 450",
barcode = c("TCGA-76-4926-01B-01D-1481-05", "TCGA-28-5211-01C-11D-1844-05"))
GDCdownload(query.met.gbm)
met.gbm.450 <- GDCprepare(query = query.met.gbm,
save = TRUE,
save.filename = "gbmDNAmet450k.rda",
summarizedExperiment = TRUE)
query.met.lgg <- GDCquery(project = "TCGA-LGG",
legacy = TRUE,
data.category = "DNA methylation",
platform = "Illumina Human Methylation 450",
barcode = c("TCGA-HT-7879-01A-11D-2399-05", "TCGA-HT-8113-01A-11D-2399-05"))
GDCdownload(query.met.lgg)
met.lgg.450 <- GDCprepare(query = query.met.lgg,
save = TRUE,
save.filename = "lggDNAmet450k.rda",
summarizedExperiment = TRUE)
met.gbm.lgg <- SummarizedExperiment::cbind(met.lgg.450, met.gbm.450)
query.exp.lgg <- GDCquery(project = "TCGA-LGG",
legacy = TRUE,
data.category = "Gene expression",
data.type = "Gene expression quantification",
platform = "Illumina HiSeq",
file.type = "results",
sample.type = "Primary solid Tumor")
GDCdownload(query.exp.lgg)
exp.lgg <- GDCprepare(query = query.exp.lgg, save = TRUE, save.filename = "lggExp.rda")
query.exp.gbm <- GDCquery(project = "TCGA-GBM",
legacy = TRUE,
data.category = "Gene expression",
data.type = "Gene expression quantification",
platform = "Illumina HiSeq",
file.type = "results",
sample.type = "Primary solid Tumor")
GDCdownload(query.exp.gbm)
exp.gbm <- GDCprepare(query = query.exp.gbm, save = TRUE, save.filename = "gbmExp.rda")
exp.gbm.lgg <- SummarizedExperiment::cbind(exp.lgg, exp.gbm)#-----------------------------------------------------------------------------
# Data.category: Copy number variation aligned to hg38
#-----------------------------------------------------------------------------
query <- GDCquery(project = "TCGA-ACC",
data.category = "Copy Number Variation",
data.type = "Copy Number Segment",
barcode = c( "TCGA-OR-A5KU-01A-11D-A29H-01", "TCGA-OR-A5JK-01A-11D-A29H-01"))
GDCdownload(query)
data <- GDCprepare(query)
query <- GDCquery("TCGA-ACC",
"Copy Number Variation",
data.type = "Masked Copy Number Segment",
sample.type = c("Primary solid Tumor")) # see the barcodes with getResults(query)$cases
GDCdownload(query)
data <- GDCprepare(query)If a SummarizedExperiment object was chosen, the data can be accessed with three different accessors: assay for the data information, rowRanges to gets the range of values in each row and colData to get the sample information (patient, batch, sample type, etc) (Huber et al. 2015; Morgan M and H., n.d.). An example is shown in listing below.
library(SummarizedExperiment)
# Load object from TCGAWorkflowData package
# THis object will be created in the further sections,
data(GBMIllumina_HiSeq)
# get expression matrix
data <- assay(gbm.exp)
data[1:5,1:5]## TCGA-28-1753-01A-01R-1850-01 TCGA-06-0749-01A-01R-1849-01
## A1BG|1 176.60 603.41
## A2M|2 23071.89 23619.77
## NAT1|9 51.00 104.00
## NAT2|10 11.00 17.00
## SERPINA3|12 8742.00 137493.00
## TCGA-28-1747-01C-01R-1850-01 TCGA-27-1834-01A-01R-1850-01
## A1BG|1 173.63 419.63
## A2M|2 41407.90 32596.30
## NAT1|9 156.00 148.00
## NAT2|10 23.00 26.00
## SERPINA3|12 127501.00 23065.00
## TCGA-28-5220-01A-01R-1850-01
## A1BG|1 217.89
## A2M|2 15286.62
## NAT1|9 79.00
## NAT2|10 22.00
## SERPINA3|12 4444.00# get genes information
genes.info <- rowRanges(gbm.exp)
genes.info## GRanges object with 21022 ranges and 4 metadata columns:
## seqnames ranges strand |
## <Rle> <IRanges> <Rle> |
## A1BG|1 chr19 [58856544, 58864865] - |
## A2M|2 chr12 [ 9220260, 9268825] - |
## NAT1|9 chr8 [18027986, 18081198] + |
## NAT2|10 chr8 [18248755, 18258728] + |
## SERPINA3|12 chr14 [95058395, 95090983] + |
## ... ... ... ... .
## NCRNA00182|100302692 chrX [ 73183790, 73513409] - |
## TMED7-TICAM2|100302736 chr5 [114914339, 114961858] - |
## TMED7-TICAM2|100302736 chr5 [114949205, 114968689] - |
## TMED7-TICAM2|100302736 chr5 [114914339, 114961876] - |
## LOC100303728|100303728 chrX [118599997, 118603061] - |
## gene_id entrezgene ensembl_gene_id
## <character> <numeric> <character>
## A1BG|1 A1BG 1 ENSG00000121410
## A2M|2 A2M 2 ENSG00000175899
## NAT1|9 NAT1 9 ENSG00000171428
## NAT2|10 NAT2 10 ENSG00000156006
## SERPINA3|12 RP11-986E7.7 12 ENSG00000273259
## ... ... ... ...
## NCRNA00182|100302692 FTX 100302692 ENSG00000230590
## TMED7-TICAM2|100302736 TMED7-TICAM2 100302736 ENSG00000251201
## TMED7-TICAM2|100302736 TMED7 100302736 ENSG00000134970
## TMED7-TICAM2|100302736 TICAM2 100302736 ENSG00000243414
## LOC100303728|100303728 SLC25A5-AS1 100303728 ENSG00000224281
## transcript_id.transcript_id_TCGA-28-1753-01A-01R-1850-01
## <character>
## A1BG|1 uc002qsd.3,uc002qsf.1
## A2M|2 uc001qvj.1,uc001qvk.1,uc009zgk.1
## NAT1|9 uc003wyq.2,uc003wyr.2,uc003wys.2,uc003wyt.2,uc003wyu.2,uc003wyv.2,uc010ltc.2,uc010ltd.2,uc011kyl.1
## NAT2|10 uc003wyw.1
## SERPINA3|12 uc001ydo.3,uc001ydp.2,uc001ydq.2,uc001ydr.2,uc001yds.2,uc010avf.1,uc010avg.2
## ... ...
## NCRNA00182|100302692 uc004ebr.1,uc010nlq.1
## TMED7-TICAM2|100302736 uc003krd.2,uc003kre.2
## TMED7-TICAM2|100302736 uc003krd.2,uc003kre.2
## TMED7-TICAM2|100302736 uc003krd.2,uc003kre.2
## LOC100303728|100303728 uc004ere.1,uc004erg.1
## -------
## seqinfo: 24 sequences from an unspecified genome; no seqlengths# get sample information
sample.info <- colData(gbm.exp)
head(sample.info) ## DataFrame with 6 rows and 106 columns
## patient barcode
## <character> <character>
## TCGA-28-1753-01A-01R-1850-01 TCGA-28-1753 TCGA-28-1753-01A-01R-1850-01
## TCGA-06-0749-01A-01R-1849-01 TCGA-06-0749 TCGA-06-0749-01A-01R-1849-01
## TCGA-28-1747-01C-01R-1850-01 TCGA-28-1747 TCGA-28-1747-01C-01R-1850-01
## TCGA-27-1834-01A-01R-1850-01 TCGA-27-1834 TCGA-27-1834-01A-01R-1850-01
## TCGA-28-5220-01A-01R-1850-01 TCGA-28-5220 TCGA-28-5220-01A-01R-1850-01
## TCGA-06-0132-01A-02R-1849-01 TCGA-06-0132 TCGA-06-0132-01A-02R-1849-01
## sample shortLetterCode
## <character> <character>
## TCGA-28-1753-01A-01R-1850-01 TCGA-28-1753-01A TP
## TCGA-06-0749-01A-01R-1849-01 TCGA-06-0749-01A TP
## TCGA-28-1747-01C-01R-1850-01 TCGA-28-1747-01C TP
## TCGA-27-1834-01A-01R-1850-01 TCGA-27-1834-01A TP
## TCGA-28-5220-01A-01R-1850-01 TCGA-28-5220-01A TP
## TCGA-06-0132-01A-02R-1849-01 TCGA-06-0132-01A TP
## definition classification_of_tumor
## <character> <character>
## TCGA-28-1753-01A-01R-1850-01 Primary solid Tumor not reported
## TCGA-06-0749-01A-01R-1849-01 Primary solid Tumor not reported
## TCGA-28-1747-01C-01R-1850-01 Primary solid Tumor not reported
## TCGA-27-1834-01A-01R-1850-01 Primary solid Tumor not reported
## TCGA-28-5220-01A-01R-1850-01 Primary solid Tumor not reported
## TCGA-06-0132-01A-02R-1849-01 Primary solid Tumor not reported
## last_known_disease_status
## <character>
## TCGA-28-1753-01A-01R-1850-01 not reported
## TCGA-06-0749-01A-01R-1849-01 not reported
## TCGA-28-1747-01C-01R-1850-01 not reported
## TCGA-27-1834-01A-01R-1850-01 not reported
## TCGA-28-5220-01A-01R-1850-01 not reported
## TCGA-06-0132-01A-02R-1849-01 not reported
## updated_datetime.x
## <character>
## TCGA-28-1753-01A-01R-1850-01 2016-09-02T19:11:19.658754-05:00
## TCGA-06-0749-01A-01R-1849-01 2016-09-02T19:01:55.836912-05:00
## TCGA-28-1747-01C-01R-1850-01 2016-09-02T19:11:33.850859-05:00
## TCGA-27-1834-01A-01R-1850-01 2016-09-02T19:12:57.685339-05:00
## TCGA-28-5220-01A-01R-1850-01 2016-09-02T19:08:48.447713-05:00
## TCGA-06-0132-01A-02R-1849-01 2016-09-02T19:13:19.722175-05:00
## primary_diagnosis tumor_stage
## <character> <character>
## TCGA-28-1753-01A-01R-1850-01 c71.9 not reported
## TCGA-06-0749-01A-01R-1849-01 c71.9 not reported
## TCGA-28-1747-01C-01R-1850-01 c71.9 not reported
## TCGA-27-1834-01A-01R-1850-01 c71.9 not reported
## TCGA-28-5220-01A-01R-1850-01 c71.9 not reported
## TCGA-06-0132-01A-02R-1849-01 c71.9 not reported
## age_at_diagnosis vital_status morphology
## <numeric> <character> <character>
## TCGA-28-1753-01A-01R-1850-01 19366 alive 9440/3
## TCGA-06-0749-01A-01R-1849-01 18571 dead 9440/3
## TCGA-28-1747-01C-01R-1850-01 16301 dead 9440/3
## TCGA-27-1834-01A-01R-1850-01 20568 dead 9440/3
## TCGA-28-5220-01A-01R-1850-01 24622 dead 9440/3
## TCGA-06-0132-01A-02R-1849-01 18125 dead 9440/3
## days_to_death
## <numeric>
## TCGA-28-1753-01A-01R-1850-01 NA
## TCGA-06-0749-01A-01R-1849-01 82
## TCGA-28-1747-01C-01R-1850-01 77
## TCGA-27-1834-01A-01R-1850-01 1233
## TCGA-28-5220-01A-01R-1850-01 388
## TCGA-06-0132-01A-02R-1849-01 771
## days_to_last_known_disease_status
## <logical>
## TCGA-28-1753-01A-01R-1850-01 NA
## TCGA-06-0749-01A-01R-1849-01 NA
## TCGA-28-1747-01C-01R-1850-01 NA
## TCGA-27-1834-01A-01R-1850-01 NA
## TCGA-28-5220-01A-01R-1850-01 NA
## TCGA-06-0132-01A-02R-1849-01 NA
## days_to_last_follow_up state.x
## <numeric> <logical>
## TCGA-28-1753-01A-01R-1850-01 37 NA
## TCGA-06-0749-01A-01R-1849-01 66 NA
## TCGA-28-1747-01C-01R-1850-01 77 NA
## TCGA-27-1834-01A-01R-1850-01 1008 NA
## TCGA-28-5220-01A-01R-1850-01 319 NA
## TCGA-06-0132-01A-02R-1849-01 570 NA
## days_to_recurrence
## <logical>
## TCGA-28-1753-01A-01R-1850-01 NA
## TCGA-06-0749-01A-01R-1849-01 NA
## TCGA-28-1747-01C-01R-1850-01 NA
## TCGA-27-1834-01A-01R-1850-01 NA
## TCGA-28-5220-01A-01R-1850-01 NA
## TCGA-06-0132-01A-02R-1849-01 NA
## diagnosis_id
## <character>
## TCGA-28-1753-01A-01R-1850-01 a0282570-3e64-5c3a-b073-9e1c169f33fc
## TCGA-06-0749-01A-01R-1849-01 8af027e1-3ad6-5221-b295-95c87f1cd184
## TCGA-28-1747-01C-01R-1850-01 b6d50cb3-6104-5cd7-a485-e1825e05aed9
## TCGA-27-1834-01A-01R-1850-01 621f8adb-470e-5586-aa0a-3845262bbfca
## TCGA-28-5220-01A-01R-1850-01 13be312a-2b28-5e0f-83ce-412c38852e5f
## TCGA-06-0132-01A-02R-1849-01 6d74ecf4-7ce5-566f-8389-d24e1617ba27
## tumor_grade
## <character>
## TCGA-28-1753-01A-01R-1850-01 not reported
## TCGA-06-0749-01A-01R-1849-01 not reported
## TCGA-28-1747-01C-01R-1850-01 not reported
## TCGA-27-1834-01A-01R-1850-01 not reported
## TCGA-28-5220-01A-01R-1850-01 not reported
## TCGA-06-0132-01A-02R-1849-01 not reported
## treatments
## <list>
## TCGA-28-1753-01A-01R-1850-01 NA,2016-09-02T19:11:19.658754-05:00,NA,...
## TCGA-06-0749-01A-01R-1849-01 NA,2016-09-02T19:01:55.836912-05:00,NA,...
## TCGA-28-1747-01C-01R-1850-01 NA,2016-09-02T19:11:33.850859-05:00,NA,...
## TCGA-27-1834-01A-01R-1850-01 NA,2016-09-02T19:12:57.685339-05:00,NA,...
## TCGA-28-5220-01A-01R-1850-01 NA,2016-09-02T19:08:48.447713-05:00,NA,...
## TCGA-06-0132-01A-02R-1849-01 NA,2016-09-02T19:13:19.722175-05:00,NA,...
## tissue_or_organ_of_origin days_to_birth
## <character> <numeric>
## TCGA-28-1753-01A-01R-1850-01 c71.9 -19366
## TCGA-06-0749-01A-01R-1849-01 c71.9 -18571
## TCGA-28-1747-01C-01R-1850-01 c71.9 -16301
## TCGA-27-1834-01A-01R-1850-01 c71.9 -20568
## TCGA-28-5220-01A-01R-1850-01 c71.9 -24622
## TCGA-06-0132-01A-02R-1849-01 c71.9 -18125
## progression_or_recurrence prior_malignancy
## <character> <character>
## TCGA-28-1753-01A-01R-1850-01 not reported not reported
## TCGA-06-0749-01A-01R-1849-01 not reported not reported
## TCGA-28-1747-01C-01R-1850-01 not reported not reported
## TCGA-27-1834-01A-01R-1850-01 not reported not reported
## TCGA-28-5220-01A-01R-1850-01 not reported not reported
## TCGA-06-0132-01A-02R-1849-01 not reported not reported
## site_of_resection_or_biopsy
## <character>
## TCGA-28-1753-01A-01R-1850-01 c71.9
## TCGA-06-0749-01A-01R-1849-01 c71.9
## TCGA-28-1747-01C-01R-1850-01 c71.9
## TCGA-27-1834-01A-01R-1850-01 c71.9
## TCGA-28-5220-01A-01R-1850-01 c71.9
## TCGA-06-0132-01A-02R-1849-01 c71.9
## created_datetime.x cigarettes_per_day
## <logical> <logical>
## TCGA-28-1753-01A-01R-1850-01 NA NA
## TCGA-06-0749-01A-01R-1849-01 NA NA
## TCGA-28-1747-01C-01R-1850-01 NA NA
## TCGA-27-1834-01A-01R-1850-01 NA NA
## TCGA-28-5220-01A-01R-1850-01 NA NA
## TCGA-06-0132-01A-02R-1849-01 NA NA
## weight updated_datetime.y
## <logical> <character>
## TCGA-28-1753-01A-01R-1850-01 NA 2016-09-02T19:11:19.658754-05:00
## TCGA-06-0749-01A-01R-1849-01 NA 2016-09-02T19:01:55.836912-05:00
## TCGA-28-1747-01C-01R-1850-01 NA 2016-09-02T19:11:33.850859-05:00
## TCGA-27-1834-01A-01R-1850-01 NA 2016-09-02T19:12:57.685339-05:00
## TCGA-28-5220-01A-01R-1850-01 NA 2016-09-02T19:08:48.447713-05:00
## TCGA-06-0132-01A-02R-1849-01 NA 2016-09-02T19:13:19.722175-05:00
## alcohol_history alcohol_intensity bmi
## <logical> <logical> <logical>
## TCGA-28-1753-01A-01R-1850-01 NA NA NA
## TCGA-06-0749-01A-01R-1849-01 NA NA NA
## TCGA-28-1747-01C-01R-1850-01 NA NA NA
## TCGA-27-1834-01A-01R-1850-01 NA NA NA
## TCGA-28-5220-01A-01R-1850-01 NA NA NA
## TCGA-06-0132-01A-02R-1849-01 NA NA NA
## years_smoked height created_datetime.y
## <logical> <logical> <logical>
## TCGA-28-1753-01A-01R-1850-01 NA NA NA
## TCGA-06-0749-01A-01R-1849-01 NA NA NA
## TCGA-28-1747-01C-01R-1850-01 NA NA NA
## TCGA-27-1834-01A-01R-1850-01 NA NA NA
## TCGA-28-5220-01A-01R-1850-01 NA NA NA
## TCGA-06-0132-01A-02R-1849-01 NA NA NA
## state.y
## <logical>
## TCGA-28-1753-01A-01R-1850-01 NA
## TCGA-06-0749-01A-01R-1849-01 NA
## TCGA-28-1747-01C-01R-1850-01 NA
## TCGA-27-1834-01A-01R-1850-01 NA
## TCGA-28-5220-01A-01R-1850-01 NA
## TCGA-06-0132-01A-02R-1849-01 NA
## exposure_id
## <character>
## TCGA-28-1753-01A-01R-1850-01 49a9d8e0-0826-5d48-8f94-5d740a11bb39
## TCGA-06-0749-01A-01R-1849-01 fe432d1c-259e-50d9-93a3-5cb54bce231b
## TCGA-28-1747-01C-01R-1850-01 130208d0-1c81-5e9c-a086-7faaa39534f7
## TCGA-27-1834-01A-01R-1850-01 88e1cef8-191c-59bf-8951-71eb48743b0f
## TCGA-28-5220-01A-01R-1850-01 e557f7ac-95a5-5cfa-9110-304a7cc3f320
## TCGA-06-0132-01A-02R-1849-01 323344b4-7ed5-597a-824c-46d8422a31de
## updated_datetime
## <character>
## TCGA-28-1753-01A-01R-1850-01 2016-09-02T19:11:19.658754-05:00
## TCGA-06-0749-01A-01R-1849-01 2016-09-02T19:01:55.836912-05:00
## TCGA-28-1747-01C-01R-1850-01 2016-09-02T19:11:33.850859-05:00
## TCGA-27-1834-01A-01R-1850-01 2016-09-02T19:12:57.685339-05:00
## TCGA-28-5220-01A-01R-1850-01 2016-09-02T19:08:48.447713-05:00
## TCGA-06-0132-01A-02R-1849-01 2016-09-02T19:13:19.722175-05:00
## created_datetime gender state
## <logical> <character> <logical>
## TCGA-28-1753-01A-01R-1850-01 NA male NA
## TCGA-06-0749-01A-01R-1849-01 NA male NA
## TCGA-28-1747-01C-01R-1850-01 NA male NA
## TCGA-27-1834-01A-01R-1850-01 NA male NA
## TCGA-28-5220-01A-01R-1850-01 NA male NA
## TCGA-06-0132-01A-02R-1849-01 NA male NA
## year_of_birth race
## <integer> <character>
## TCGA-28-1753-01A-01R-1850-01 1956 white
## TCGA-06-0749-01A-01R-1849-01 1958 black or african american
## TCGA-28-1747-01C-01R-1850-01 1964 white
## TCGA-27-1834-01A-01R-1850-01 1950 white
## TCGA-28-5220-01A-01R-1850-01 1943 white
## TCGA-06-0132-01A-02R-1849-01 1958 white
## demographic_id
## <character>
## TCGA-28-1753-01A-01R-1850-01 51ee4685-9d81-5e77-a3d8-73b6fc8f60be
## TCGA-06-0749-01A-01R-1849-01 383ca7c3-aed0-545f-9939-f8092f2894b1
## TCGA-28-1747-01C-01R-1850-01 16269cae-c6f3-5c91-997b-15a045259f11
## TCGA-27-1834-01A-01R-1850-01 d21c4b05-e2d5-5f3f-84f6-1dd0b2c2f9ab
## TCGA-28-5220-01A-01R-1850-01 dcb6fe26-48c9-510f-9b19-bdda92036b66
## TCGA-06-0132-01A-02R-1849-01 1ad48cdc-c76d-5770-af41-1fcefef18284
## ethnicity year_of_death
## <character> <integer>
## TCGA-28-1753-01A-01R-1850-01 hispanic or latino NA
## TCGA-06-0749-01A-01R-1849-01 not hispanic or latino 2008
## TCGA-28-1747-01C-01R-1850-01 not hispanic or latino 2008
## TCGA-27-1834-01A-01R-1850-01 not hispanic or latino 2009
## TCGA-28-5220-01A-01R-1850-01 not reported NA
## TCGA-06-0132-01A-02R-1849-01 not hispanic or latino 2009
## bcr_patient_barcode dbgap_accession_number
## <character> <logical>
## TCGA-28-1753-01A-01R-1850-01 TCGA-28-1753 NA
## TCGA-06-0749-01A-01R-1849-01 TCGA-06-0749 NA
## TCGA-28-1747-01C-01R-1850-01 TCGA-28-1747 NA
## TCGA-27-1834-01A-01R-1850-01 TCGA-27-1834 NA
## TCGA-28-5220-01A-01R-1850-01 TCGA-28-5220 NA
## TCGA-06-0132-01A-02R-1849-01 TCGA-06-0132 NA
## disease_type released state.1
## <character> <logical> <character>
## TCGA-28-1753-01A-01R-1850-01 Glioblastoma Multiforme TRUE legacy
## TCGA-06-0749-01A-01R-1849-01 Glioblastoma Multiforme TRUE legacy
## TCGA-28-1747-01C-01R-1850-01 Glioblastoma Multiforme TRUE legacy
## TCGA-27-1834-01A-01R-1850-01 Glioblastoma Multiforme TRUE legacy
## TCGA-28-5220-01A-01R-1850-01 Glioblastoma Multiforme TRUE legacy
## TCGA-06-0132-01A-02R-1849-01 Glioblastoma Multiforme TRUE legacy
## primary_site project_id
## <character> <character>
## TCGA-28-1753-01A-01R-1850-01 Brain TCGA-GBM
## TCGA-06-0749-01A-01R-1849-01 Brain TCGA-GBM
## TCGA-28-1747-01C-01R-1850-01 Brain TCGA-GBM
## TCGA-27-1834-01A-01R-1850-01 Brain TCGA-GBM
## TCGA-28-5220-01A-01R-1850-01 Brain TCGA-GBM
## TCGA-06-0132-01A-02R-1849-01 Brain TCGA-GBM
## name subtype_patient
## <character> <factor>
## TCGA-28-1753-01A-01R-1850-01 Glioblastoma Multiforme TCGA-28-1753
## TCGA-06-0749-01A-01R-1849-01 Glioblastoma Multiforme TCGA-06-0749
## TCGA-28-1747-01C-01R-1850-01 Glioblastoma Multiforme TCGA-28-1747
## TCGA-27-1834-01A-01R-1850-01 Glioblastoma Multiforme TCGA-27-1834
## TCGA-28-5220-01A-01R-1850-01 Glioblastoma Multiforme TCGA-28-5220
## TCGA-06-0132-01A-02R-1849-01 Glioblastoma Multiforme TCGA-06-0132
## subtype_Tissue.source.site
## <factor>
## TCGA-28-1753-01A-01R-1850-01 Cedars Sinai
## TCGA-06-0749-01A-01R-1849-01 Henry Ford Hospital
## TCGA-28-1747-01C-01R-1850-01 Cedars Sinai
## TCGA-27-1834-01A-01R-1850-01 Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta
## TCGA-28-5220-01A-01R-1850-01 Cedars Sinai
## TCGA-06-0132-01A-02R-1849-01 Henry Ford Hospital
## subtype_Study subtype_BCR
## <factor> <factor>
## TCGA-28-1753-01A-01R-1850-01 Glioblastoma multiforme IGC
## TCGA-06-0749-01A-01R-1849-01 Glioblastoma multiforme IGC
## TCGA-28-1747-01C-01R-1850-01 Glioblastoma multiforme IGC
## TCGA-27-1834-01A-01R-1850-01 Glioblastoma multiforme IGC
## TCGA-28-5220-01A-01R-1850-01 Glioblastoma multiforme IGC
## TCGA-06-0132-01A-02R-1849-01 Glioblastoma multiforme IGC
## subtype_Whole.exome subtype_Whole.genome
## <factor> <factor>
## TCGA-28-1753-01A-01R-1850-01 Yes No
## TCGA-06-0749-01A-01R-1849-01 Yes No
## TCGA-28-1747-01C-01R-1850-01 Yes No
## TCGA-27-1834-01A-01R-1850-01 Yes No
## TCGA-28-5220-01A-01R-1850-01 Yes No
## TCGA-06-0132-01A-02R-1849-01 Yes No
## subtype_RNAseq subtype_SNP6 subtype_U133a
## <factor> <factor> <factor>
## TCGA-28-1753-01A-01R-1850-01 Yes Yes Yes
## TCGA-06-0749-01A-01R-1849-01 Yes Yes Yes
## TCGA-28-1747-01C-01R-1850-01 Yes Yes Yes
## TCGA-27-1834-01A-01R-1850-01 Yes Yes Yes
## TCGA-28-5220-01A-01R-1850-01 Yes Yes Yes
## TCGA-06-0132-01A-02R-1849-01 Yes Yes Yes
## subtype_HM450 subtype_HM27 subtype_RPPA
## <factor> <factor> <factor>
## TCGA-28-1753-01A-01R-1850-01 No Yes Yes
## TCGA-06-0749-01A-01R-1849-01 No No No
## TCGA-28-1747-01C-01R-1850-01 No Yes Yes
## TCGA-27-1834-01A-01R-1850-01 No Yes Yes
## TCGA-28-5220-01A-01R-1850-01 Yes No No
## TCGA-06-0132-01A-02R-1849-01 No No No
## subtype_Histology subtype_Grade
## <factor> <factor>
## TCGA-28-1753-01A-01R-1850-01 glioblastoma G4
## TCGA-06-0749-01A-01R-1849-01 glioblastoma G4
## TCGA-28-1747-01C-01R-1850-01 glioblastoma G4
## TCGA-27-1834-01A-01R-1850-01 glioblastoma G4
## TCGA-28-5220-01A-01R-1850-01 glioblastoma G4
## TCGA-06-0132-01A-02R-1849-01 glioblastoma G4
## subtype_Age..years.at.diagnosis.
## <integer>
## TCGA-28-1753-01A-01R-1850-01 53
## TCGA-06-0749-01A-01R-1849-01 50
## TCGA-28-1747-01C-01R-1850-01 44
## TCGA-27-1834-01A-01R-1850-01 56
## TCGA-28-5220-01A-01R-1850-01 67
## TCGA-06-0132-01A-02R-1849-01 49
## subtype_Gender subtype_Survival..months.
## <factor> <numeric>
## TCGA-28-1753-01A-01R-1850-01 male 1.215631
## TCGA-06-0749-01A-01R-1849-01 male 2.694102
## TCGA-28-1747-01C-01R-1850-01 male 2.529827
## TCGA-27-1834-01A-01R-1850-01 male 40.510092
## TCGA-28-5220-01A-01R-1850-01 male 10.480713
## TCGA-06-0132-01A-02R-1849-01 male 25.331128
## subtype_Vital.status..1.dead.
## <integer>
## TCGA-28-1753-01A-01R-1850-01 0
## TCGA-06-0749-01A-01R-1849-01 1
## TCGA-28-1747-01C-01R-1850-01 1
## TCGA-27-1834-01A-01R-1850-01 1
## TCGA-28-5220-01A-01R-1850-01 0
## TCGA-06-0132-01A-02R-1849-01 1
## subtype_Karnofsky.Performance.Score
## <integer>
## TCGA-28-1753-01A-01R-1850-01 NA
## TCGA-06-0749-01A-01R-1849-01 NA
## TCGA-28-1747-01C-01R-1850-01 NA
## TCGA-27-1834-01A-01R-1850-01 80
## TCGA-28-5220-01A-01R-1850-01 90
## TCGA-06-0132-01A-02R-1849-01 NA
## subtype_Mutation.Count
## <integer>
## TCGA-28-1753-01A-01R-1850-01 45
## TCGA-06-0749-01A-01R-1849-01 49
## TCGA-28-1747-01C-01R-1850-01 41
## TCGA-27-1834-01A-01R-1850-01 41
## TCGA-28-5220-01A-01R-1850-01 35
## TCGA-06-0132-01A-02R-1849-01 23
## subtype_Percent.aneuploidy subtype_IDH.status
## <numeric> <factor>
## TCGA-28-1753-01A-01R-1850-01 0.1271441 WT
## TCGA-06-0749-01A-01R-1849-01 0.1562720 WT
## TCGA-28-1747-01C-01R-1850-01 0.1091594 WT
## TCGA-27-1834-01A-01R-1850-01 0.5039493 WT
## TCGA-28-5220-01A-01R-1850-01 0.6261002 WT
## TCGA-06-0132-01A-02R-1849-01 NA WT
## subtype_X1p.19q.codeletion
## <factor>
## TCGA-28-1753-01A-01R-1850-01 non-codel
## TCGA-06-0749-01A-01R-1849-01 non-codel
## TCGA-28-1747-01C-01R-1850-01 non-codel
## TCGA-27-1834-01A-01R-1850-01 non-codel
## TCGA-28-5220-01A-01R-1850-01 non-codel
## TCGA-06-0132-01A-02R-1849-01 non-codel
## subtype_IDH.codel.subtype
## <factor>
## TCGA-28-1753-01A-01R-1850-01 IDHwt
## TCGA-06-0749-01A-01R-1849-01 IDHwt
## TCGA-28-1747-01C-01R-1850-01 IDHwt
## TCGA-27-1834-01A-01R-1850-01 IDHwt
## TCGA-28-5220-01A-01R-1850-01 IDHwt
## TCGA-06-0132-01A-02R-1849-01 IDHwt
## subtype_MGMT.promoter.status
## <factor>
## TCGA-28-1753-01A-01R-1850-01 Unmethylated
## TCGA-06-0749-01A-01R-1849-01 NA
## TCGA-28-1747-01C-01R-1850-01 Methylated
## TCGA-27-1834-01A-01R-1850-01 Methylated
## TCGA-28-5220-01A-01R-1850-01 Unmethylated
## TCGA-06-0132-01A-02R-1849-01 NA
## subtype_Chr.7.gain.Chr.10.loss
## <factor>
## TCGA-28-1753-01A-01R-1850-01 Gain chr 7 & loss chr 10
## TCGA-06-0749-01A-01R-1849-01 Gain chr 7 & loss chr 10
## TCGA-28-1747-01C-01R-1850-01 No combined CNA
## TCGA-27-1834-01A-01R-1850-01 Gain chr 7 & loss chr 10
## TCGA-28-5220-01A-01R-1850-01 Gain chr 7 & loss chr 10
## TCGA-06-0132-01A-02R-1849-01 No combined CNA
## subtype_Chr.19.20.co.gain
## <factor>
## TCGA-28-1753-01A-01R-1850-01 No chr 19/20 gain
## TCGA-06-0749-01A-01R-1849-01 No chr 19/20 gain
## TCGA-28-1747-01C-01R-1850-01 No chr 19/20 gain
## TCGA-27-1834-01A-01R-1850-01 No chr 19/20 gain
## TCGA-28-5220-01A-01R-1850-01 No chr 19/20 gain
## TCGA-06-0132-01A-02R-1849-01 No chr 19/20 gain
## subtype_TERT.promoter.status
## <factor>
## TCGA-28-1753-01A-01R-1850-01 NA
## TCGA-06-0749-01A-01R-1849-01 NA
## TCGA-28-1747-01C-01R-1850-01 NA
## TCGA-27-1834-01A-01R-1850-01 NA
## TCGA-28-5220-01A-01R-1850-01 NA
## TCGA-06-0132-01A-02R-1849-01 NA
## subtype_TERT.expression..log2.
## <numeric>
## TCGA-28-1753-01A-01R-1850-01 5.727920
## TCGA-06-0749-01A-01R-1849-01 2.584963
## TCGA-28-1747-01C-01R-1850-01 5.554589
## TCGA-27-1834-01A-01R-1850-01 1.000000
## TCGA-28-5220-01A-01R-1850-01 3.700440
## TCGA-06-0132-01A-02R-1849-01 0.000000
## subtype_TERT.expression.status
## <factor>
## TCGA-28-1753-01A-01R-1850-01 Expressed
## TCGA-06-0749-01A-01R-1849-01 Expressed
## TCGA-28-1747-01C-01R-1850-01 Expressed
## TCGA-27-1834-01A-01R-1850-01 Not expressed
## TCGA-28-5220-01A-01R-1850-01 Expressed
## TCGA-06-0132-01A-02R-1849-01 Not expressed
## subtype_ATRX.status subtype_DAXX.status
## <factor> <factor>
## TCGA-28-1753-01A-01R-1850-01 WT WT
## TCGA-06-0749-01A-01R-1849-01 WT WT
## TCGA-28-1747-01C-01R-1850-01 WT WT
## TCGA-27-1834-01A-01R-1850-01 WT WT
## TCGA-28-5220-01A-01R-1850-01 WT WT
## TCGA-06-0132-01A-02R-1849-01 WT WT
## subtype_Telomere.Maintenance
## <factor>
## TCGA-28-1753-01A-01R-1850-01 NA
## TCGA-06-0749-01A-01R-1849-01 NA
## TCGA-28-1747-01C-01R-1850-01 NA
## TCGA-27-1834-01A-01R-1850-01 NA
## TCGA-28-5220-01A-01R-1850-01 NA
## TCGA-06-0132-01A-02R-1849-01 NA
## subtype_BRAF.V600E.status
## <factor>
## TCGA-28-1753-01A-01R-1850-01 WT
## TCGA-06-0749-01A-01R-1849-01 WT
## TCGA-28-1747-01C-01R-1850-01 WT
## TCGA-27-1834-01A-01R-1850-01 WT
## TCGA-28-5220-01A-01R-1850-01 WT
## TCGA-06-0132-01A-02R-1849-01 WT
## subtype_BRAF.KIAA1549.fusion
## <factor>
## TCGA-28-1753-01A-01R-1850-01 WT
## TCGA-06-0749-01A-01R-1849-01 WT
## TCGA-28-1747-01C-01R-1850-01 WT
## TCGA-27-1834-01A-01R-1850-01 WT
## TCGA-28-5220-01A-01R-1850-01 WT
## TCGA-06-0132-01A-02R-1849-01 WT
## subtype_ABSOLUTE.purity
## <numeric>
## TCGA-28-1753-01A-01R-1850-01 0.62
## TCGA-06-0749-01A-01R-1849-01 0.57
## TCGA-28-1747-01C-01R-1850-01 0.80
## TCGA-27-1834-01A-01R-1850-01 0.76
## TCGA-28-5220-01A-01R-1850-01 0.89
## TCGA-06-0132-01A-02R-1849-01 0.27
## subtype_ABSOLUTE.ploidy
## <numeric>
## TCGA-28-1753-01A-01R-1850-01 2.00
## TCGA-06-0749-01A-01R-1849-01 1.95
## TCGA-28-1747-01C-01R-1850-01 1.96
## TCGA-27-1834-01A-01R-1850-01 1.91
## TCGA-28-5220-01A-01R-1850-01 1.83
## TCGA-06-0132-01A-02R-1849-01 1.95
## subtype_ESTIMATE.stromal.score
## <numeric>
## TCGA-28-1753-01A-01R-1850-01 2509.6100
## TCGA-06-0749-01A-01R-1849-01 981.3623
## TCGA-28-1747-01C-01R-1850-01 850.3133
## TCGA-27-1834-01A-01R-1850-01 1005.6140
## TCGA-28-5220-01A-01R-1850-01 440.0687
## TCGA-06-0132-01A-02R-1849-01 2673.8230
## subtype_ESTIMATE.immune.score
## <numeric>
## TCGA-28-1753-01A-01R-1850-01 2893.989
## TCGA-06-0749-01A-01R-1849-01 2495.874
## TCGA-28-1747-01C-01R-1850-01 2574.148
## TCGA-27-1834-01A-01R-1850-01 2487.626
## TCGA-28-5220-01A-01R-1850-01 1904.311
## TCGA-06-0132-01A-02R-1849-01 3265.700
## subtype_ESTIMATE.combined.score
## <numeric>
## TCGA-28-1753-01A-01R-1850-01 5403.599
## TCGA-06-0749-01A-01R-1849-01 3477.237
## TCGA-28-1747-01C-01R-1850-01 3424.462
## TCGA-27-1834-01A-01R-1850-01 3493.239
## TCGA-28-5220-01A-01R-1850-01 2344.380
## TCGA-06-0132-01A-02R-1849-01 5939.523
## subtype_Original.Subtype
## <factor>
## TCGA-28-1753-01A-01R-1850-01 Mesenchymal
## TCGA-06-0749-01A-01R-1849-01 Neural
## TCGA-28-1747-01C-01R-1850-01 Classical
## TCGA-27-1834-01A-01R-1850-01 Neural
## TCGA-28-5220-01A-01R-1850-01 Classical
## TCGA-06-0132-01A-02R-1849-01 Neural
## subtype_Transcriptome.Subtype
## <factor>
## TCGA-28-1753-01A-01R-1850-01 ME
## TCGA-06-0749-01A-01R-1849-01 NE
## TCGA-28-1747-01C-01R-1850-01 CL
## TCGA-27-1834-01A-01R-1850-01 NA
## TCGA-28-5220-01A-01R-1850-01 NA
## TCGA-06-0132-01A-02R-1849-01 NE
## subtype_Pan.Glioma.RNA.Expression.Cluster
## <factor>
## TCGA-28-1753-01A-01R-1850-01 LGr4
## TCGA-06-0749-01A-01R-1849-01 LGr4
## TCGA-28-1747-01C-01R-1850-01 LGr4
## TCGA-27-1834-01A-01R-1850-01 LGr4
## TCGA-28-5220-01A-01R-1850-01 LGr4
## TCGA-06-0132-01A-02R-1849-01 LGr2
## subtype_IDH.specific.RNA.Expression.Cluster
## <factor>
## TCGA-28-1753-01A-01R-1850-01 IDHwt-R3
## TCGA-06-0749-01A-01R-1849-01 IDHwt-R4
## TCGA-28-1747-01C-01R-1850-01 IDHwt-R3
## TCGA-27-1834-01A-01R-1850-01 IDHwt-R2
## TCGA-28-5220-01A-01R-1850-01 IDHwt-R2
## TCGA-06-0132-01A-02R-1849-01 IDHwt-R4
## subtype_Pan.Glioma.DNA.Methylation.Cluster
## <factor>
## TCGA-28-1753-01A-01R-1850-01 LGm5
## TCGA-06-0749-01A-01R-1849-01 NA
## TCGA-28-1747-01C-01R-1850-01 LGm5
## TCGA-27-1834-01A-01R-1850-01 LGm5
## TCGA-28-5220-01A-01R-1850-01 LGm5
## TCGA-06-0132-01A-02R-1849-01 NA
## subtype_IDH.specific.DNA.Methylation.Cluster
## <factor>
## TCGA-28-1753-01A-01R-1850-01 IDHwt-K2
## TCGA-06-0749-01A-01R-1849-01 NA
## TCGA-28-1747-01C-01R-1850-01 IDHwt-K2
## TCGA-27-1834-01A-01R-1850-01 IDHwt-K2
## TCGA-28-5220-01A-01R-1850-01 IDHwt-K2
## TCGA-06-0132-01A-02R-1849-01 NA
## subtype_Supervised.DNA.Methylation.Cluster
## <factor>
## TCGA-28-1753-01A-01R-1850-01 Mesenchymal-like
## TCGA-06-0749-01A-01R-1849-01 NA
## TCGA-28-1747-01C-01R-1850-01 Mesenchymal-like
## TCGA-27-1834-01A-01R-1850-01 Mesenchymal-like
## TCGA-28-5220-01A-01R-1850-01 Mesenchymal-like
## TCGA-06-0132-01A-02R-1849-01 NA
## subtype_Random.Forest.Sturm.Cluster
## <factor>
## TCGA-28-1753-01A-01R-1850-01 NA
## TCGA-06-0749-01A-01R-1849-01 NA
## TCGA-28-1747-01C-01R-1850-01 NA
## TCGA-27-1834-01A-01R-1850-01 NA
## TCGA-28-5220-01A-01R-1850-01 RTK II 'Classic'
## TCGA-06-0132-01A-02R-1849-01 NA
## subtype_RPPA.cluster
## <factor>
## TCGA-28-1753-01A-01R-1850-01 K1
## TCGA-06-0749-01A-01R-1849-01 NA
## TCGA-28-1747-01C-01R-1850-01 K1
## TCGA-27-1834-01A-01R-1850-01 K1
## TCGA-28-5220-01A-01R-1850-01 NA
## TCGA-06-0132-01A-02R-1849-01 NA
## subtype_Telomere.length.estimate.in.blood.normal..Kb.
## <numeric>
## TCGA-28-1753-01A-01R-1850-01 NA
## TCGA-06-0749-01A-01R-1849-01 NA
## TCGA-28-1747-01C-01R-1850-01 NA
## TCGA-27-1834-01A-01R-1850-01 NA
## TCGA-28-5220-01A-01R-1850-01 NA
## TCGA-06-0132-01A-02R-1849-01 NA
## subtype_Telomere.length.estimate.in.tumor..Kb.
## <numeric>
## TCGA-28-1753-01A-01R-1850-01 NA
## TCGA-06-0749-01A-01R-1849-01 NA
## TCGA-28-1747-01C-01R-1850-01 NA
## TCGA-27-1834-01A-01R-1850-01 NA
## TCGA-28-5220-01A-01R-1850-01 NA
## TCGA-06-0132-01A-02R-1849-01 NAThe clinical data can be obtained using TCGAbiolinks through two methods. The first one will download only the indexed GDC clinical data which includes diagnoses (vital status, days to death, age at diagnosis, days to last follow up, days to recurrence), treatments (days to treatment, treatment id, therapeutic agents, treatment intent type), demographic (gender, race, ethnicity) and exposures (cigarettes per day, weight, height, alcohol history) information. This indexed clinical data can be obtained using the function GDCquery_clinical which can be used as described in listing below. This function has two arguments project (“TCGA-GBM”,“TARGET-AML”,etc) and type (“Clinical” or “Biospecimen”). The second method will download the xml files with all clinical data for the patient and retrieve the desired information from it. This will give access to all clinical data available which includes patient (tumor tissue site, histological type, gender, vital status, days to birth, days to last follow up, etc), drug (days to drug therapy start, days to drug therapy end, therapy types, drug name), radiation (days to radiation therapy start, days to radiation therapy end, radiation type, radiation dosage ), new tumor event (days to new tumor event after initial treatment, new neoplasm event type, additional pharmaceutical therapy), follow up (primary therapy outcome success, follow up treatment success, vital status, days to last follow up, date of form completion), stage event (pathologic stage, tnm categories), admin (batch number, project code, disease code, Biospecimen Core Resource).
# get indexed clinical patient data for GBM samples
gbm_clin <- GDCquery_clinic(project = "TCGA-GBM", type = "Clinical")
# get indexed clinical patient data for LGG samples
lgg_clin <- GDCquery_clinic(project = "TCGA-LGG", type = "Clinical")
# Bind the results, as the columns might not be the same,
# we will will plyr rbind.fill, to have all columns from both files
clinical <- plyr::rbind.fill(gbm_clin,lgg_clin)head(clinical) ## submitter_id classification_of_tumor last_known_disease_status
## 1 TCGA-02-0001 not reported not reported
## 2 TCGA-02-0003 not reported not reported
## 3 TCGA-02-0004 not reported not reported
## 4 TCGA-02-0006 not reported not reported
## 5 TCGA-02-0007 not reported not reported
## 6 TCGA-02-0009 not reported not reported
## updated_datetime primary_diagnosis tumor_stage
## 1 2017-03-04T16:44:35.784223-06:00 c71.9 not reported
## 2 2017-03-04T16:44:35.784223-06:00 c71.9 not reported
## 3 2017-03-04T16:44:35.784223-06:00 c71.9 not reported
## 4 2017-03-04T16:44:35.784223-06:00 c71.9 not reported
## 5 2017-03-04T16:44:35.784223-06:00 c71.9 not reported
## 6 2017-03-04T16:44:35.784223-06:00 c71.9 not reported
## age_at_diagnosis vital_status morphology days_to_death
## 1 16179 dead 9440/3 358
## 2 18341 dead 9440/3 144
## 3 21617 dead 9440/3 345
## 4 20516 dead 9440/3 558
## 5 14806 dead 9440/3 705
## 6 22457 dead 9440/3 322
## days_to_last_known_disease_status created_datetime state
## 1 NA NA live
## 2 NA NA live
## 3 NA NA live
## 4 NA NA live
## 5 NA NA live
## 6 NA NA live
## days_to_recurrence diagnosis_id tumor_grade
## 1 NA e99b166c-a599-5d2e-9534-f660e3b18a84 not reported
## 2 NA 6b9e2d98-e6cd-5c0b-8e38-1a851c07ac64 not reported
## 3 NA 7a2d4e0b-7492-5f85-ba22-311d363d97e7 not reported
## 4 NA 4023ae86-3936-5648-90ec-e7cdc64ee012 not reported
## 5 NA bbdde045-6918-52da-8a68-00a350b73c51 not reported
## 6 NA 5eea7161-1261-5481-a941-b89eb1c4cf70 not reported
## tissue_or_organ_of_origin days_to_birth progression_or_recurrence
## 1 c71.9 -16179 not reported
## 2 c71.9 -18341 not reported
## 3 c71.9 -21617 not reported
## 4 c71.9 -20516 not reported
## 5 c71.9 -14806 not reported
## 6 c71.9 -22457 not reported
## prior_malignancy site_of_resection_or_biopsy days_to_last_follow_up
## 1 not reported c71.9 279
## 2 not reported c71.9 144
## 3 not reported c71.9 345
## 4 not reported c71.9 558
## 5 not reported c71.9 705
## 6 not reported c71.9 322
## cigarettes_per_day weight alcohol_history alcohol_intensity bmi
## 1 NA NA NA NA NA
## 2 NA NA NA NA NA
## 3 NA NA NA NA NA
## 4 NA NA NA NA NA
## 5 NA NA NA NA NA
## 6 NA NA NA NA NA
## years_smoked exposure_id height gender
## 1 NA 5a04d603-02a9-527e-b4da-24e450cbdf87 NA female
## 2 NA ad77c843-36de-58bb-83d7-37437cb2e7f2 NA male
## 3 NA f836e994-6e80-5ff1-9fcc-1c2c320391da NA male
## 4 NA 3e2c7703-2ed3-5555-9c1d-0301c684c7a5 NA female
## 5 NA 7ca8fa74-2ff8-562a-94ae-682a73a31902 NA female
## 6 NA 8b18c7a4-a6ea-5cd4-91b0-634d62400b45 NA female
## year_of_birth race demographic_id
## 1 1958 white 3a9037c5-e664-542c-9306-2201e017e523
## 2 1953 white b3d375be-0fe4-527a-8b7e-a537551a61a5
## 3 1943 white 10aedf8e-4e75-54ca-adeb-a0f792b95d8e
## 4 1946 white 8a707557-d498-5ff6-9700-f2625b944b95
## 5 1962 white a167b83d-15ec-5061-b53b-fb62e672db3c
## 6 1942 white 9ec62946-28d0-5316-888e-c096184e797a
## ethnicity year_of_death therapeutic_agents
## 1 not hispanic or latino 2002 NA
## 2 not hispanic or latino 2003 NA
## 3 not hispanic or latino 2002 NA
## 4 not hispanic or latino 2003 NA
## 5 not hispanic or latino 2003 NA
## 6 not hispanic or latino 2003 NA
## treatment_id days_to_treatment
## 1 17db47ee-d5ad-53e4-a686-d28b5412c1ec NA
## 2 75c15d67-5fb5-5cae-8712-bbfb14d4de2d NA
## 3 fd026dcf-374c-5c56-9a6b-3c4c37fa6199 NA
## 4 ca94eeb8-8ead-5268-ac42-08fd1b5163b2 NA
## 5 5cbaf906-94c7-5396-b6b5-e88c18b9817a NA
## 6 c4622b4d-bed7-509b-b507-50210e438303 NA
## treatment_intent_type treatment_or_therapy bcr_patient_barcode disease
## 1 NA NA TCGA-02-0001 GBM
## 2 NA NA TCGA-02-0003 GBM
## 3 NA NA TCGA-02-0004 GBM
## 4 NA NA TCGA-02-0006 GBM
## 5 NA NA TCGA-02-0007 GBM
## 6 NA NA TCGA-02-0009 GBM# Fetch clinical data directly from the clinical XML files.
# if barcode is not set, it will consider all samples.
# We only set it to make the example faster
query <- GDCquery(project = "TCGA-GBM",
data.category = "Clinical",
barcode = c("TCGA-08-0516","TCGA-02-0317"))
GDCdownload(query)
clinical <- GDCprepare_clinic(query, clinical.info = "patient")head(clinical) ## additional_studies tumor_tissue_site histological_type
## 1 NA Brain Untreated primary (de novo) GBM
## 2 NA Brain Untreated primary (de novo) GBM
## prior_glioma gender vital_status days_to_birth days_to_death
## 1 NO MALE Dead -5309 596
## 2 NO MALE Dead -14636 372
## days_to_last_followup race_list bcr_patient_barcode tissue_source_site
## 1 561 WHITE TCGA-08-0516 8
## 2 372 WHITE TCGA-02-0317 2
## patient_id bcr_patient_uuid
## 1 516 b0ebaa85-476c-4f44-8b23-5bab107454a9
## 2 317 6879e9da-dacf-48b3-8e95-760796f96a1b
## informed_consent_verified icd_o_3_site icd_o_3_histology icd_10
## 1 YES C71.9 9440/3 C71.9
## 2 YES C71.9 9440/3 C71.9
## tissue_prospective_collection_indicator
## 1 NA
## 2 NA
## tissue_retrospective_collection_indicator
## 1 NA
## 2 NA
## days_to_initial_pathologic_diagnosis age_at_initial_pathologic_diagnosis
## 1 0 14
## 2 0 40
## year_of_initial_pathologic_diagnosis person_neoplasm_cancer_status
## 1 2001 WITH TUMOR
## 2 1994 WITH TUMOR
## day_of_form_completion month_of_form_completion year_of_form_completion
## 1 11 12 2008
## 2 17 12 2008
## ethnicity other_dx history_of_neoadjuvant_treatment
## 1 NOT HISPANIC OR LATINO NA No
## 2 NOT HISPANIC OR LATINO NA No
## initial_pathologic_diagnosis_method init_pathology_dx_method_other
## 1 Tumor resection NA
## 2 Tumor resection NA
## anatomic_neoplasm_subdivision radiation_therapy postoperative_rx_tx
## 1 NA NA NA
## 2 NA NA NA
## primary_therapy_outcome_success karnofsky_performance_score
## 1 NA NA
## 2 NA 80
## eastern_cancer_oncology_group performance_status_scale_timing
## 1 NA NA
## 2 NA NA
## has_new_tumor_events_information has_drugs_information
## 1 NO NO
## 2 NO YES
## has_radiations_information has_follow_ups_information
## 1 YES YES
## 2 YES YESclinical.drug <- GDCprepare_clinic(query, clinical.info = "drug")head(clinical.drug)## tx_on_clinical_trial regimen_number bcr_drug_barcode
## 1 NA NA TCGA-02-0317-D22476
## bcr_drug_uuid total_dose total_dose_units
## 1 91d4a74b-253a-403c-a8b0-d11fe903c32b NA NA
## prescribed_dose prescribed_dose_units number_cycles
## 1 NA NA NA
## days_to_drug_therapy_start days_to_drug_therapy_end therapy_types
## 1 23 176 Chemotherapy
## drug_name clinical_trail_drug_classification regimen_indication
## 1 anti neopastons NA ADJUVANT
## regimen_indication_notes route_of_administrations therapy_ongoing
## 1 NA NA NA
## measure_of_response day_of_form_completion month_of_form_completion
## 1 NA 27 3
## year_of_form_completion bcr_patient_barcode
## 1 2009 TCGA-02-0317clinical.radiation <- GDCprepare_clinic(query, clinical.info = "radiation")head(clinical.radiation)## bcr_radiation_barcode bcr_radiation_uuid
## 1 TCGA-08-0516-R23304 e7390ac0-7d2f-4452-83d8-304919b45c17
## 2 TCGA-08-0516-R23305 50499afc-f3d0-4194-a2e5-a15271c22251
## 3 TCGA-02-0317-R22477 264bf3d4-7479-4d24-814b-0188b17a7526
## days_to_radiation_therapy_start days_to_radiation_therapy_end
## 1 10 40
## 2 171 171
## 3 NA NA
## radiation_type radiation_type_notes radiation_dosage units numfractions
## 1 EXTERNAL BEAM NA NA NA NA
## 2 IMPLANTS NA NA NA NA
## 3 EXTERNAL BEAM NA NA NA NA
## anatomic_treatment_site regimen_indication regimen_indication_notes
## 1 Primary Tumor Field ADJUVANT NA
## 2 PROGRESSION NA
## 3 Primary Tumor Field ADJUVANT NA
## radiation_treatment_ongoing course_number measure_of_response
## 1 NO NA NA
## 2 NO NA NA
## 3 NA NA
## day_of_form_completion month_of_form_completion year_of_form_completion
## 1 11 12 2008
## 2 11 12 2008
## 3 27 3 2009
## bcr_patient_barcode
## 1 TCGA-08-0516
## 2 TCGA-08-0516
## 3 TCGA-02-0317clinical.admin <- GDCprepare_clinic(query, clinical.info = "admin")head(clinical.admin)## bcr file_uuid
## 1 Nationwide Children's Hospital 8C65AA78-D60C-4367-92F6-9BAD27E33AFC
## 2 Nationwide Children's Hospital 21DE62FD-3CD7-413D-8F3B-E76DE3F138B3
## batch_number project_code disease_code day_of_dcc_upload
## 1 5.89.0 TCGA GBM 31
## 2 5.89.0 TCGA GBM 31
## month_of_dcc_upload year_of_dcc_upload patient_withdrawal
## 1 3 2016 false
## 2 3 2016 false
## bcr_patient_barcode
## 1 TCGA-08-0516
## 2 TCGA-02-0317Mutation information is stored in two types of Mutation Annotation Format (MAF): Protected and Somatic (or Public) MAF files, which are derived from the GDC annotated VCF files. Annotated VCF files often have variants reported on multiple transcripts whereas the protected MAF (*protected.maf) only reports the most critically affected one and the Somatic MAFs (*somatic.maf) are further processed to remove low quality and potential germline variants. To download Somatic MAFs data using TCGAbiolinks, GDCquery_maf function is provided (see listing below).
LGGmut <- GDCquery_Maf(tumor = "LGG", pipelines = "mutect2")data(mafMutect2LGGGBM)
head(LGGmut)## # A tibble: 6 x 114
## Hugo_Symbol Entrez_Gene_Id Center NCBI_Build Chromosome Start_Position
## <chr> <int> <chr> <chr> <chr> <int>
## 1 FBN2 2201 BI GRCh38 chr5 128305070
## 2 RP11-368M16.8 0 BI GRCh38 chr7 57653425
## 3 LIMK1 3984 BI GRCh38 chr7 74105957
## 4 PDGFRL 5157 BI GRCh38 chr8 17589503
## 5 ACER2 340485 BI GRCh38 chr9 19435026
## 6 KCNT1 57582 BI GRCh38 chr9 135784546
## # ... with 108 more variables: End_Position <int>, Strand <chr>,
## # Variant_Classification <chr>, Variant_Type <chr>,
## # Reference_Allele <chr>, Tumor_Seq_Allele1 <chr>,
## # Tumor_Seq_Allele2 <chr>, dbSNP_RS <chr>, dbSNP_Val_Status <chr>,
## # Tumor_Sample_Barcode <chr>, Matched_Norm_Sample_Barcode <chr>,
## # Match_Norm_Seq_Allele1 <chr>, Match_Norm_Seq_Allele2 <chr>,
## # Tumor_Validation_Allele1 <chr>, Tumor_Validation_Allele2 <chr>,
## # Match_Norm_Validation_Allele1 <chr>,
## # Match_Norm_Validation_Allele2 <chr>, Verification_Status <chr>,
## # Validation_Status <chr>, Mutation_Status <chr>,
## # Sequencing_Phase <chr>, Sequence_Source <chr>,
## # Validation_Method <chr>, Score <chr>, BAM_File <chr>, Sequencer <chr>,
## # Tumor_Sample_UUID <chr>, Matched_Norm_Sample_UUID <chr>, HGVSc <chr>,
## # HGVSp <chr>, HGVSp_Short <chr>, Transcript_ID <chr>,
## # Exon_Number <chr>, t_depth <int>, t_ref_count <int>,
## # t_alt_count <int>, n_depth <int>, n_ref_count <chr>,
## # n_alt_count <chr>, all_effects <chr>, Allele <chr>, Gene <chr>,
## # Feature <chr>, Feature_type <chr>, Consequence <chr>,
## # cDNA_position <chr>, CDS_position <chr>, Protein_position <chr>,
## # Amino_acids <chr>, Codons <chr>, Existing_variation <chr>,
## # ALLELE_NUM <int>, DISTANCE <chr>, TRANSCRIPT_STRAND <int>,
## # SYMBOL <chr>, SYMBOL_SOURCE <chr>, HGNC_ID <chr>, BIOTYPE <chr>,
## # CANONICAL <chr>, CCDS <chr>, ENSP <chr>, SWISSPROT <chr>,
## # TREMBL <chr>, UNIPARC <chr>, RefSeq <chr>, SIFT <chr>, PolyPhen <chr>,
## # EXON <chr>, INTRON <chr>, DOMAINS <chr>, GMAF <chr>, AFR_MAF <chr>,
## # AMR_MAF <chr>, ASN_MAF <chr>, EAS_MAF <chr>, EUR_MAF <chr>,
## # SAS_MAF <chr>, AA_MAF <chr>, EA_MAF <chr>, CLIN_SIG <chr>,
## # SOMATIC <dbl>, PUBMED <dbl>, MOTIF_NAME <chr>, MOTIF_POS <chr>,
## # HIGH_INF_POS <chr>, MOTIF_SCORE_CHANGE <chr>, IMPACT <chr>,
## # PICK <int>, VARIANT_CLASS <chr>, TSL <int>, HGVS_OFFSET <int>,
## # PHENO <dbl>, MINIMISED <int>, ExAC_AF <dbl>, ExAC_AF_AFR <int>,
## # ExAC_AF_AMR <int>, ExAC_AF_EAS <int>, ExAC_AF_FIN <int>,
## # ExAC_AF_NFE <dbl>, ExAC_AF_OTH <int>, ...Finally, the Cancer Genome Atlas (TCGA) Research Network has reported integrated genome-wide studies of various diseases (ACC (Zheng et al. 2016), BRCA (C. G. A. Network and others 2012b), COAD (C. G. A. Network and others 2012a), GBM (Ceccarelli et al. 2016), HNSC (C. G. A. Network and others 2015a), KICH (Davis et al. 2014), KIRC (Network and others 2013), KIRP (Network and others 2016), LGG (Ceccarelli et al. 2016), LUAD (Network and others 2014c), LUSC (Network and others 2012), PRAD (Network and others 2015), READ (C. G. A. Network and others 2012a), SKCM (C. G. A. Network and others 2015b), STAD (Network and others 2014a), THCA (Network and others 2014d) and UCEC (Network and others 2014b)) which classified them in different subtypes. This classification can be retrieved using the TCGAquery_subtype function or by accessing the samples information in the SummarizedExperiment object that created by the GDCprepare function, which automatically incorporates it into the object.
gbm.subtypes <- TCGAquery_subtype(tumor = "gbm")head(gbm.subtypes)## patient Tissue.source.site Study BCR
## 517 TCGA-02-0001 MD Anderson Cancer Center Glioblastoma multiforme IGC
## 518 TCGA-02-0003 MD Anderson Cancer Center Glioblastoma multiforme IGC
## 519 TCGA-02-0004 MD Anderson Cancer Center Glioblastoma multiforme IGC
## 520 TCGA-02-0006 MD Anderson Cancer Center Glioblastoma multiforme IGC
## 521 TCGA-02-0007 MD Anderson Cancer Center Glioblastoma multiforme IGC
## 522 TCGA-02-0009 MD Anderson Cancer Center Glioblastoma multiforme IGC
## Whole.exome Whole.genome RNAseq SNP6 U133a HM450 HM27 RPPA
## 517 No No No Yes Yes No Yes No
## 518 Yes No No Yes Yes No Yes Yes
## 519 No No No No Yes No No Yes
## 520 No No No Yes No No Yes No
## 521 No No No Yes Yes No Yes No
## 522 No No No Yes Yes No Yes No
## Histology Grade Age..years.at.diagnosis. Gender Survival..months.
## 517 glioblastoma G4 44 female 11.762054
## 518 glioblastoma G4 50 male 4.731106
## 519 glioblastoma G4 59 male 11.334941
## 520 glioblastoma G4 56 female 18.333034
## 521 glioblastoma G4 40 female 23.162705
## 522 glioblastoma G4 61 female 10.579278
## Vital.status..1.dead. Karnofsky.Performance.Score Mutation.Count
## 517 1 80 NA
## 518 1 100 52
## 519 1 80 NA
## 520 1 80 NA
## 521 1 80 NA
## 522 1 80 NA
## Percent.aneuploidy IDH.status X1p.19q.codeletion IDH.codel.subtype
## 517 0.4249000 WT non-codel IDHwt
## 518 0.1479882 WT non-codel IDHwt
## 519 0.1178814 WT <NA> <NA>
## 520 0.2390546 WT non-codel IDHwt
## 521 0.2574537 WT non-codel IDHwt
## 522 0.1596193 WT non-codel IDHwt
## MGMT.promoter.status Chr.7.gain.Chr.10.loss Chr.19.20.co.gain
## 517 Unmethylated Gain chr 7 & loss chr 10 No chr 19/20 gain
## 518 Unmethylated Gain chr 7 & loss chr 10 No chr 19/20 gain
## 519 <NA> <NA> <NA>
## 520 Unmethylated Gain chr 7 & loss chr 10 No chr 19/20 gain
## 521 Unmethylated No combined CNA No chr 19/20 gain
## 522 Unmethylated Gain chr 7 & loss chr 10 No chr 19/20 gain
## TERT.promoter.status TERT.expression..log2. TERT.expression.status
## 517 <NA> NA <NA>
## 518 <NA> NA <NA>
## 519 <NA> NA <NA>
## 520 <NA> NA <NA>
## 521 <NA> NA <NA>
## 522 <NA> NA <NA>
## ATRX.status DAXX.status Telomere.Maintenance BRAF.V600E.status
## 517 <NA> <NA> <NA> <NA>
## 518 WT WT <NA> WT
## 519 <NA> <NA> <NA> <NA>
## 520 <NA> <NA> <NA> <NA>
## 521 <NA> <NA> <NA> <NA>
## 522 <NA> <NA> <NA> <NA>
## BRAF.KIAA1549.fusion ABSOLUTE.purity ABSOLUTE.ploidy
## 517 <NA> 0.49 3.47
## 518 <NA> 0.90 1.96
## 519 <NA> NA NA
## 520 <NA> 0.60 1.93
## 521 <NA> 0.93 1.89
## 522 <NA> 0.90 1.99
## ESTIMATE.stromal.score ESTIMATE.immune.score ESTIMATE.combined.score
## 517 NA NA NA
## 518 NA NA NA
## 519 NA NA NA
## 520 NA NA NA
## 521 NA NA NA
## 522 NA NA NA
## Original.Subtype Transcriptome.Subtype
## 517 Classical NE
## 518 Proneural PN
## 519 Mesenchymal ME
## 520 Mesenchymal ME
## 521 Proneural <NA>
## 522 Classical CL
## Pan.Glioma.RNA.Expression.Cluster IDH.specific.RNA.Expression.Cluster
## 517 LGr4 <NA>
## 518 LGr4 <NA>
## 519 LGr4 <NA>
## 520 <NA> <NA>
## 521 unclassified <NA>
## 522 LGr4 <NA>
## Pan.Glioma.DNA.Methylation.Cluster
## 517 LGm5
## 518 LGm5
## 519 <NA>
## 520 LGm5
## 521 LGm4
## 522 LGm4
## IDH.specific.DNA.Methylation.Cluster
## 517 IDHwt-K2
## 518 IDHwt-K2
## 519 <NA>
## 520 IDHwt-K2
## 521 IDHwt-K1
## 522 IDHwt-K1
## Supervised.DNA.Methylation.Cluster Random.Forest.Sturm.Cluster
## 517 Mesenchymal-like <NA>
## 518 Mesenchymal-like <NA>
## 519 <NA> <NA>
## 520 Mesenchymal-like <NA>
## 521 Classic-like <NA>
## 522 Classic-like <NA>
## RPPA.cluster Telomere.length.estimate.in.blood.normal..Kb.
## 517 <NA> NA
## 518 K1 NA
## 519 K1 NA
## 520 <NA> NA
## 521 <NA> NA
## 522 <NA> NA
## Telomere.length.estimate.in.tumor..Kb.
## 517 NA
## 518 NA
## 519 NA
## 520 NA
## 521 NA
## 522 NA4.1.2 Downloading data from Broad TCGA GDAC
The Bioconductor package RTCGAToolbox (Samur 2014) provides access to Firehose Level 3 and 4 data through the function getFirehoseData. The following arguments allows users to select the version and tumor type of interest:
dataset - Tumor to download. A complete list of possibilities can be viewed with getFirehoseDatasets function.
runDate - Stddata run dates. Dates can be viewed with getFirehoseRunningDates function.
gistic2_Date - Analyze run dates. Dates can viewed with getFirehoseAnalyzeDates function.
These arguments can be used to select the data type to download: RNAseq_Gene, Clinic, miRNASeq_Gene, ccRNAseq2_Gene_Norm, CNA_SNP, CNV_SNP, CNA_Seq, CNA_CGH, Methylation, Mutation, mRNA_Array , miRNA_Array, and RPPA.
By default, RTCGAToolbox allows users to download up to 500 MB worth of data. To increase the size of the download, users are encouraged to use fileSizeLimit argument. An example is found in listingbelow. The getData function allow users to access the downloaded data (see lines 22-24 of listing below as a S4Vector object.
library(RTCGAToolbox)# Get the last run dates
lastRunDate <- getFirehoseRunningDates()[1]
# get DNA methylation data, RNAseq2 and clinical data for GBM
gbm.data <- getFirehoseData(dataset = "GBM",
runDate = lastRunDate, gistic2_Date = getFirehoseAnalyzeDates(1),
Methylation = FALSE, Clinic = TRUE,
RNAseq2_Gene_Norm = FALSE, Mutation = TRUE,
fileSizeLimit = 10000)
gbm.mut <- getData(gbm.data,"Mutations")
gbm.clin <- getData(gbm.data,"Clinical")Finnaly, RTCGAToolbox can access level 4 data, which can be handy when the user requires GISTIC results. GISTIC is used to identify genes targeted by somatic copy-number alterations (SCNAs) (Mermel et al. 2011).
# Download GISTIC results
lastAnalyseDate <- getFirehoseAnalyzeDates(1)
gistic <- getFirehoseData("GBM",gistic2_Date = lastAnalyseDate)
# get GISTIC results
gistic.allbygene <- getData(gistic,type = "GISTIC", CN = "All")
gistic.thresholedbygene <- getData(gistic,type = "GISTIC", CN = "Thresholed")data(GBMGistic)
gistic.allbygene[1:5,1:5]## Gene.Symbol Locus.ID Cytoband TCGA.02.0001.01C.01D.0182.01
## 1 ACAP3 116983 1p36.33 0.242
## 2 ACTRT2 140625 1p36.32 0.242
## 3 AGRN 375790 1p36.33 0.242
## 4 ANKRD65 441869 1p36.33 0.242
## 5 ATAD3A 55210 1p36.33 0.242
## TCGA.02.0003.01A.01D.0182.01
## 1 0.007
## 2 0.007
## 3 0.007
## 4 0.007
## 5 0.007gistic.thresholedbygene[1:5,1:5]## Gene.Symbol Locus.ID Cytoband TCGA.02.0001.01C.01D.0182.01
## 1 ACAP3 116983 1p36.33 1
## 2 ACTRT2 140625 1p36.32 1
## 3 AGRN 375790 1p36.33 1
## 4 ANKRD65 441869 1p36.33 1
## 5 ATAD3A 55210 1p36.33 1
## TCGA.02.0003.01A.01D.0182.01
## 1 0
## 2 0
## 3 0
## 4 0
## 5 04.2 Genomic analysis
Copy number variations (CNVs) have a critical role in cancer development and progression. A chromosomal segment can be deleted or amplified as a result of genomic rearrangements, such as deletions, duplications, insertions and translocations. CNVs are genomic regions greater than 1 kb with an alteration of copy number between two conditions (e.g., Tumor versus Normal).
TCGA collects copy number data and allows the CNV profiling of cancer. Tumor and paired-normal DNA samples were analysed for CNV detection using microarray- and sequencing-based technologies. Level 3 processed data are the aberrant regions along the genome resulting from CNV segmentation, and they are available for all copy number technologies.
In this section, we will show how to analyze CNV level 3 data from TCGA to identify recurrent alterations in cancer genome. We analyzed GBM segmented CNV from SNP array (Affymetrix Genome-Wide Human SNP Array 6.0).
Pre-Processing Data
The only CNV platform available for GBM in TCGA is “Affymetrix Genome-Wide Human SNP Array 6.0”. Using TCGAbiolinks, we queried for CNV SNP6 level 3 data for 20 primary solid tumor samples in the legacy database. Data for selected samples were downloaded and prepared in a rse objects (RangedSummarizedExperiment).
library(TCGAbiolinks)
# Select common CN technology available for GBM and LGG
#############################
## CNV data pre-processing ##
#############################
query.gbm.nocnv <- GDCquery(project = "TCGA-GBM",
data.category = "Copy number variation",
legacy = TRUE,
file.type = "nocnv_hg19.seg",
sample.type = c("Primary solid Tumor"))
# to reduce time we will select only 20 samples
query.gbm.nocnv$results[[1]] <- query.gbm.nocnv$results[[1]][1:20,]
GDCdownload(query.gbm.nocnv, chunks.per.download = 100)
gbm.nocnv <- GDCprepare(query.gbm.nocnv, save = TRUE, save.filename = "GBMnocnvhg19.rda")4.2.1 Identification of recurrent CNV in cancer
Cancer related CNV have to be present in many of the analyzed genomes. The most significant recurrent CNV were identified using GAIA (Morganella, Pagnotta, and Ceccarelli, n.d.), an iterative procedure where a statistical hypothesis framework is extended to take into account within-sample homogeneity. GAIA is based on a conservative permutation test allowing the estimation of the probability distribution of the contemporary mutations expected for non-driver markers.
Segmented data retrieved from TCGA were used to generate a matrix including all needed information about the observed aberrant regions. Furthermore, GAIA requires genomic probes metadata (specific for each CNV technology), that can be downloaded from broadinstitute website.
# -=-=-=-=-=-=-=-=-=-=-=-=-=-=-=--=-==--=--==---=-=-=-=-=-=-=-=-=-=-=-=-=-=-=--=-==--=--==--
# Retrieve probes meta file from broadinstitute website for hg19
# For hg38 analysis please take a look on:
# https://gdc.cancer.gov/about-data/data-harmonization-and-generation/gdc-reference-files
# File: SNP6 GRCh38 Liftover Probeset File for Copy Number Variation Analysis
# -=-=-=-=-=-=-=-=-=-=-=-=-=-=-=--=-==--=--==---=-=-=-=-=-=-=-=-=-=-=-=-=-=-=--=-==--=--==--
gdac.root <- "ftp://ftp.broadinstitute.org/pub/GISTIC2.0/hg19_support/"
file <- paste0(gdac.root, "genome.info.6.0_hg19.na31_minus_frequent_nan_probes_sorted_2.1.txt")
if(!file.exists(basename(file))) downloader::download(file, basename(file))
markersMatrix <- readr::read_tsv(basename(file), col_names = FALSE, col_types = "ccn", progress = FALSE)
save(markersMatrix, file = "markersMatrix.rda", compress = "xz")cancer <- "GBM"
message(paste0("Starting ", cancer))
# get objects created above
data(GBMnocnvhg19)
data(markersMatrix)
# Add label (0 for loss, 1 for gain)
cnvMatrix <- cbind(cnvMatrix,Label=NA)
cnvMatrix[cnvMatrix[,"Segment_Mean"] < -0.3,"Label"] <- 0
cnvMatrix[cnvMatrix[,"Segment_Mean"] > 0.3,"Label"] <- 1
cnvMatrix <- cnvMatrix[!is.na(cnvMatrix$Label),]
# Remove "Segment_Mean" and change col.names
cnvMatrix <- cnvMatrix[,-6]
colnames(cnvMatrix) <- c("Sample.Name", "Chromosome", "Start", "End", "Num.of.Markers", "Aberration")
# Substitute Chromosomes "X" and "Y" with "23" and "24"
cnvMatrix[cnvMatrix$Chromosome == "X","Chromosome"] <- 23
cnvMatrix[cnvMatrix$Chromosome == "Y","Chromosome"] <- 24
cnvMatrix$Chromosome <- as.integer(cnvMatrix$Chromosome)
# Recurrent CNV identification with GAIA
colnames(markersMatrix) <- c("Probe.Name", "Chromosome", "Start")
unique(markersMatrix$Chromosome)## [1] "1" "2" "3" "4" "5" "6" "7" "8" "9" "10" "11" "12" "13" "14"
## [15] "15" "16" "17" "18" "19" "20" "21" "22" "X" "Y"markersMatrix[markersMatrix$Chromosome == "X","Chromosome"] <- 23
markersMatrix[markersMatrix$Chromosome == "Y","Chromosome"] <- 24
markersMatrix$Chromosome <- as.integer(markersMatrix$Chromosome)
markerID <- paste(markersMatrix$Chromosome,markersMatrix$Start, sep = ":")
# Removed duplicates
markersMatrix <- markersMatrix[!duplicated(markerID),]
# Filter markersMatrix for common CNV
markerID <- paste(markersMatrix$Chromosome,markersMatrix$Start, sep = ":")
file <- "ftp://ftp.broadinstitute.org/pub/GISTIC2.0/hg19_support/CNV.hg19.bypos.111213.txt"
if(!file.exists(basename(file))) downloader::download(file, basename(file))
commonCNV <- readr::read_tsv(basename(file), progress = FALSE)
commonID <- paste(commonCNV$Chromosome,commonCNV$Start, sep = ":")
markersMatrix_fil <- markersMatrix[!markerID %in% commonID,]
library(gaia)
set.seed(200)
markers_obj <- load_markers(as.data.frame(markersMatrix_fil))
nbsamples <- length(unique(cnvMatrix$Sample))
cnv_obj <- load_cnv(cnvMatrix, markers_obj, nbsamples)
suppressWarnings({
results <- runGAIA(cnv_obj,
markers_obj,
output_file_name = paste0("GAIA_",cancer,"_flt.txt"),
aberrations = -1, # -1 to all aberrations
chromosomes = 9, # -1 to all chromosomes
approximation = TRUE, # Set to TRUE to speed up the time requirements
num_iterations = 5000, # Reduced to speed up the time requirements
threshold = 0.25)
})
# Set q-value threshold
# Use a smalled value for your analysis. We set this as high values
# due to the small number of samples which did not reproduced
# results with smaller q-values
threshold <- 0.3
# Plot the results
RecCNV <- t(apply(results,1,as.numeric))
colnames(RecCNV) <- colnames(results)
RecCNV <- cbind(RecCNV, score = 0)
minval <- format(min(RecCNV[RecCNV[,"q-value"] != 0,"q-value"]), scientific = FALSE)
minval <- substring(minval,1, nchar(minval) - 1)
RecCNV[RecCNV[,"q-value"] == 0,"q-value"] <- as.numeric(minval)
RecCNV[,"score"] <- sapply(RecCNV[,"q-value"],function(x) -log10(as.numeric(x)))
RecCNV[RecCNV[,"q-value"] == as.numeric(minval),]## Chromosome Aberration Kind Region Start [bp] Region End [bp]
## 1 9 0 18259823 18387361
## 2 9 0 19290143 19485455
## 3 9 0 19535498 26257238
## 4 9 0 26433917 26725609
## 5 9 0 26834232 27009100
## Region Size [bp] q-value score
## 1 127539 0.00875417 2.057785
## 2 195313 0.00875417 2.057785
## 3 6721741 0.00875417 2.057785
## 4 291693 0.00875417 2.057785
## 5 174869 0.00875417 2.057785gaiaCNVplot(RecCNV,threshold)
save(results, RecCNV, threshold, file = paste0(cancer,"_CNV_results.rda"))Recurrent amplifications and deletions were identified for GBM, and represented in chromosomal overview plots by a statistical score (\(-log_{10}\) corrected p-value for amplifications and \(log_{10}\) corrected p-value for deletions). Genomic regions identified as significantly altered in copy number (corrected p-value < \(10^{-4}\)) were then annotated to report amplified and deleted genes potentially related with cancer.
4.2.2 Gene annotation of recurrent CNV
The aberrant recurrent genomic regions in cancer, as identified by GAIA, have to be annotated to verify which genes are significantly amplified or deleted. Using biomaRt we retrieved the genomic ranges of all human genes and we compared them with significant aberrant regions to select full length genes.
library(GenomicRanges)
# Get gene information from GENCODE using biomart
genes <- TCGAbiolinks:::get.GRCh.bioMart(genome = "hg19")
genes <- genes[genes$external_gene_id != "" & genes$chromosome_name %in% c(1:22,"X","Y"),]
genes[genes$chromosome_name == "X", "chromosome_name"] <- 23
genes[genes$chromosome_name == "Y", "chromosome_name"] <- 24
genes$chromosome_name <- sapply(genes$chromosome_name,as.integer)
genes <- genes[order(genes$start_position),]
genes <- genes[order(genes$chromosome_name),]
genes <- genes[,c("external_gene_id", "chromosome_name", "start_position","end_position")]
colnames(genes) <- c("GeneSymbol","Chr","Start","End")
genes_GR <- makeGRangesFromDataFrame(genes,keep.extra.columns = TRUE)
save(genes_GR,genes,file = "genes_GR.rda", compress = "xz")##############################
## Recurrent CNV annotation ##
##############################
# Get gene information from GENCODE using biomart
data(genes_GR) # downloaded in the previous step (available in TCGAWorkflowData)
load(paste0(cancer,"_CNV_results.rda"))
sCNV <- RecCNV[RecCNV[,"q-value"] <= threshold,c(1:4,6)]
sCNV <- sCNV[order(sCNV[,3]),]
sCNV <- sCNV[order(sCNV[,1]),]
colnames(sCNV) <- c("Chr","Aberration","Start","End","q-value")
sCNV_GR <- makeGRangesFromDataFrame(sCNV,keep.extra.columns = TRUE)
hits <- findOverlaps(genes_GR, sCNV_GR, type = "within")
sCNV_ann <- cbind(sCNV[subjectHits(hits),],genes[queryHits(hits),])
AberrantRegion <- paste0(sCNV_ann[,1],":",sCNV_ann[,3],"-",sCNV_ann[,4])
GeneRegion <- paste0(sCNV_ann[,7],":",sCNV_ann[,8],"-",sCNV_ann[,9])
AmpDel_genes <- cbind(sCNV_ann[,c(6,2,5)],AberrantRegion,GeneRegion)
AmpDel_genes[AmpDel_genes[,2] == 0,2] <- "Del"
AmpDel_genes[AmpDel_genes[,2] == 1,2] <- "Amp"
rownames(AmpDel_genes) <- NULL
save(RecCNV, AmpDel_genes, file = paste0(cancer,"_CNV_results.rda"))| GeneSymbol | Aberration | q-value | AberrantRegion | GeneRegion |
|---|---|---|---|---|
| C9orf92 | Del | 0.0087542 | 9:16000812-18259760 | 9:16203933-16276311 |
| BNC2 | Del | 0.0087542 | 9:16000812-18259760 | 9:16409501-16870841 |
| RP11-183I6.2 | Del | 0.0087542 | 9:16000812-18259760 | 9:16473186-16476235 |
| RP11-62F24.1 | Del | 0.0087542 | 9:16000812-18259760 | 9:16625674-16626388 |
| RP11-62F24.2 | Del | 0.0087542 | 9:16000812-18259760 | 9:16726812-16727522 |
| RP11-335H2.2 | Del | 0.0087542 | 9:16000812-18259760 | 9:16775571-16775843 |
4.2.3 Visualizing multiple genomic alteration events
In order to visualize multiple genomic alteration events we recommend using OncoPrint plot which is provided by Bioconductor package complexHeatmap (Z., n.d.). The listing below shows how to download mutation data using GDCquery_maf (line 4), then we filtered the genes to obtain genes with mutations found among glioma specific pathways (lines 6 - 12). The following steps prepared the data into a matrix to fit oncoPrint function. We defined SNPs as blue, insertions as green and deletions as red. The upper barplot indicates the number of genetic mutation per patient, while the right barplot shows the number of genetic mutations per gene. Also, it is possible to add annotations to rows or columns. For the columns, an insertion made at the top will remove the barplot. The final result for adding the annotation to the bottom is highlighted in the figure .
LGGmut <- GDCquery_Maf(tumor = "LGG", pipelines = "mutect2")
GBMmut <- GDCquery_Maf(tumor = "GBM", pipelines = "mutect2")
mut <- plyr::rbind.fill(LGGmut, GBMmut)
save(mut,file ="mafMutect2LGGGBM.rda")library(ComplexHeatmap)
# recovering data from TCGAWorkflowData package.
data(mafMutect2LGGGBM)
# Filtering mutations in gliomas
EA_pathways <- TCGAbiolinks:::listEA_pathways
Glioma_pathways <- EA_pathways[grep("glioma", tolower(EA_pathways$Pathway)),]
Glioma_signaling <- Glioma_pathways[Glioma_pathways$Pathway == "Glioma Signaling",]
Glioma_signaling_genes <- unlist(strsplit(as.character(Glioma_signaling$Molecules),","))[1:10]
mut <- mut[mut$Hugo_Symbol %in% Glioma_signaling_genes,]
clinical <- plyr::rbind.fill(gbm_clin,lgg_clin)TCGAvisualize_oncoprint(mut = mut,
gene = Glioma_signaling_genes,
annotation = clinical[, c("bcr_patient_barcode","disease","vital_status","ethnicity")],
annotation.position = "bottom",
rm.empty.columns = FALSE)
Oncoprint for LGG samples. Blue defines SNP, green defines insertions and red defines deletions. The upper barplot shows the number of these genetic mutation for each patient, while the right barplot shows the number of genetic mutations for each gene. The bottom bar shows the group of each sample.
Overview of genomic alterations by circos plot
Genomic alterations in cancer, including CNV and mutations, can be represented in an effective overview plot named circos. We used circlize CRAN package to represent significant CNV (resulting from GAIA analysis) and recurrent mutations (selecting curated genetic variations retrieved from TCGA that are identified in at least two tumor samples) in LGG. Circos plot can illustrate molecular alterations genome-wide or only in one or more selected chromosomes.
LGGmut <- GDCquery_Maf(tumor = "LGG", pipelines = "mutect2")###############################################
## Genomic aberration overview - Circos plot ##
###############################################
# Retrieve curated mutations for selected cancer (e.g. "LGG")
data(mafMutect2LGGGBM)
# Select only potentially damaging mutations
LGGmut <- LGGmut[LGGmut$Variant_Classification %in% c("Missense_Mutation",
"Nonsense_Mutation",
"Nonstop_Mutation",
"Frame_Shift_Del",
"Frame_Shift_Ins"),]
# Select recurrent mutations (identified in at least two samples)
mut.id <- paste0(LGGmut$Chromosome,":",LGGmut$Start_Position,"-",LGGmut$End_Position,"|",LGGmut$Reference_Allele)
mut <- cbind(mut.id, LGGmut)
# Prepare selected mutations data for circos plot
s.mut <- mut[mut$mut.id %in% unique(mut.id[duplicated(mut.id)]),]
s.mut <- s.mut[,c("Chromosome","Start_Position","End_Position","Variant_Classification","Hugo_Symbol")]
s.mut <- unique(s.mut)
typeNames <- unique(s.mut[,4])
type <- c(4:1)
names(type) <- typeNames[1:4]
Type <- type[s.mut[,4]]
s.mut <- cbind(s.mut,Type)
s.mut <- s.mut[,c(1:3,6,4,5)]
# Load recurrent CNV data for selected cancer (e.g. "LGG")
load("GBM_CNV_results.rda")
# Prepare selected sample CNV data for circos plot
s.cnv <- as.data.frame(RecCNV[RecCNV[,"q-value"] <= threshold,c(1:4,6)])
s.cnv <- s.cnv[,c(1,3,4,2)]
s.cnv[s.cnv$Chromosome == 23,"Chromosome"] <- "X"
s.cnv[s.cnv$Chromosome == 24,"Chromosome"] <- "Y"
Chromosome <- paste0("chr",s.cnv[,1])
s.cnv <- cbind(Chromosome, s.cnv[,-1])
s.cnv[,1] <- as.character(s.cnv[,1])
s.cnv[,4] <- as.character(s.cnv[,4])
s.cnv <- cbind(s.cnv,CNV=1)
colnames(s.cnv) <- c("Chromosome","Start_position","End_position","Aberration_Kind","CNV")
library(circlize)
# Draw genomic circos plot
par(mar=c(1,1,1,1), cex=1)
circos.initializeWithIdeogram()
# Add CNV results
colors <- c("forestgreen","firebrick")
names(colors) <- c(0,1)
circos.genomicTrackPlotRegion(s.cnv, ylim = c(0,1.2),
panel.fun = function(region, value, ...) {
circos.genomicRect(region, value, ytop.column = 2, ybottom = 0,
col = colors[value[[1]]],
border="white")
cell.xlim = get.cell.meta.data("cell.xlim")
circos.lines(cell.xlim, c(0, 0), lty = 2, col = "#00000040")
})
# Add mutation results
colors <- c("blue","green","red","gold")
names(colors) <- typeNames[1:4]
circos.genomicTrackPlotRegion(s.mut, ylim = c(1.2,4.2),
panel.fun = function(region, value, ...) {
circos.genomicPoints(region, value, cex = 0.8, pch = 16, col = colors[value[[2]]], ...)
})
circos.clear()
legend(-0.2, 0.2, bty="n", y.intersp=1, c("Amp","Del"), pch=15,
col=c("firebrick","forestgreen"), title="CNVs", text.font=1, cex=0.4, title.adj=0)
legend(-0.2, 0, bty="n", y.intersp=1, names(colors), pch=16,
col=colors, title="Mutations", text.font=1, cex=0.4, title.adj=0)
par(mar=c(1,1,1,1),cex=1.5)
circos.par("start.degree" = 90, canvas.xlim = c(0, 1), canvas.ylim = c(0, 1),
gap.degree = 270, cell.padding = c(0, 0, 0, 0), track.margin = c(0.005, 0.005))
circos.initializeWithIdeogram(chromosome.index = "chr17")
circos.par(cell.padding = c(0, 0, 0, 0))
# Add CNV results
colors <- c("forestgreen","firebrick")
names(colors) <- c(0,1)
circos.genomicTrackPlotRegion(s.cnv, ylim = c(0,1.2),
panel.fun = function(region, value, ...) {
circos.genomicRect(region, value, ytop.column = 2, ybottom = 0,
col = colors[value[[1]]],
border="white")
cell.xlim = get.cell.meta.data("cell.xlim")
circos.lines(cell.xlim, c(0, 0), lty = 2, col = "#00000040")
})
# Add mutation results representing single genes
genes.mut <- paste0(s.mut$Hugo_Symbol,"-",s.mut$Type)
s.mutt <- cbind(s.mut,genes.mut)
n.mut <- table(genes.mut)
idx <- !duplicated(s.mutt$genes.mut)
s.mutt <- s.mutt[idx,]
s.mutt <- cbind(s.mutt,num=n.mut[s.mutt$genes.mut])
genes.num <- paste0(s.mutt$Hugo_Symbol," (",s.mutt$num.Freq,")")
s.mutt <- cbind(s.mutt[,-c(6:8)],genes.num)
s.mutt[,6] <- as.character(s.mutt[,6])
s.mutt[,4] <- s.mutt[,4]/2
s.mutt$num.Freq <- NULL
colors <- c("blue","green","red","gold")
names(colors) <- typeNames[1:4]
circos.genomicTrackPlotRegion(s.mutt, ylim = c(0.3,2.2), track.height = 0.05,
panel.fun = function(region, value, ...) {
circos.genomicPoints(region, value, cex = 0.4, pch = 16, col = colors[value[[2]]], ...)
})
circos.genomicTrackPlotRegion(s.mutt, ylim = c(0, 1), track.height = 0.1, bg.border = NA)
i_track = get.cell.meta.data("track.index")
circos.genomicTrackPlotRegion(s.mutt, ylim = c(0,1),
panel.fun = function(region, value, ...) {
circos.genomicText(region, value,
y = 1,
labels.column = 3,
col = colors[value[[2]]],
facing = "clockwise", adj = c(1, 0.5),
posTransform = posTransform.text, cex = 0.4, niceFacing = TRUE)
}, track.height = 0.1, bg.border = NA)
circos.genomicPosTransformLines(s.mutt,
posTransform = function(region, value)
posTransform.text(region,
y = 1,
labels = value[[3]],
cex = 0.4, track.index = i_track+1),
direction = "inside", track.index = i_track)
circos.clear()
legend(0.25, 0.2, bty="n", y.intersp=1, c("Amp","Del"), pch=15,
col=c("firebrick","forestgreen"), title="CNVs", text.font=1, cex=0.4, title.adj=0)
legend(0, 0.2, bty="n", y.intersp=1, names(colors), pch=16,
col=colors, title="Mutations", text.font=1, cex=0.4, title.adj=0)
4.3 Transcriptomic analysis
4.3.1 Pre-Processing Data
The LGG and GBM data used for following transcriptomic analysis were downloaded using TCGAbiolinks. We downloaded only primary solid tumor (TP) samples, which resulted in 516 LGG samples and 156 GBM samples, then prepared it in two separate rse objects (RangedSummarizedExperiment) saving them as an R object with a filename including both the name of the cancer and the name of the plaftorm used for gene expression data (see listing below).
query <- GDCquery(project = "TCGA-GBM",
data.category = "Gene expression",
data.type = "Gene expression quantification",
platform = "Illumina HiSeq",
file.type = "results",
sample.type = c("Primary solid Tumor"),
legacy = TRUE)
# We will use only 20 samples to make the example faster
query$results[[1]] <- query$results[[1]][1:20,]
GDCdownload(query)
gbm.exp <- GDCprepare(query,
save = TRUE,
summarizedExperiment = TRUE,
save.filename = "GBMIllumina_HiSeq.rda")
query <- GDCquery(project = "TCGA-LGG",
data.category = "Gene expression",
data.type = "Gene expression quantification",
platform = "Illumina HiSeq",
file.type = "results",
sample.type = c("Primary solid Tumor"),
legacy = TRUE)
# We will use only 20 samples to make the example faster
query$results[[1]] <- query$results[[1]][1:20,]
GDCdownload(query)
lgg.exp <- GDCprepare(query,
save = TRUE,
summarizedExperiment = TRUE,
save.filename = "LGGIllumina_HiSeq.rda")To pre-process the data, first, we searched for possible outliers using the TCGAanalyze_Preprocessing function, which performs an Array Array Intensity correlation AAIC (lines 14-17 and 26-29 of listing below). In this way we defined a square symmetric matrix of pearson correlation among all samples in each cancer type (LGG or GBM). This matrix found 0 samples with low correlation (cor.cut = 0.6) that can be identified as possible outliers.
Second, using the TCGAanalyze_Normalization function, which encompasses the functions of the EDASeq package, we normalized mRNA transcripts.
This function implements Within-lane normalization procedures to adjust for GC-content effect (or other gene-level effects) on read counts: loess robust local regression, global-scaling, and full-quantile normalization (Risso et al. 2011) and between-lane normalization procedures to adjust for distributional differences between lanes (e.g., sequencing depth): global-scaling and full-quantile normalization (Bullard et al. 2010).
data("LGGIllumina_HiSeq")
data("GBMIllumina_HiSeq")
dataPrep_LGG <- TCGAanalyze_Preprocessing(object = lgg.exp,
cor.cut = 0.6,
datatype = "raw_count",
filename = "LGG_IlluminaHiSeq_RNASeqV2.png")
dataPrep_GBM <- TCGAanalyze_Preprocessing(object = gbm.exp,
cor.cut = 0.6,
datatype = "raw_count",
filename = "GBM_IlluminaHiSeq_RNASeqV2.png")
dataNorm <- TCGAanalyze_Normalization(tabDF = cbind(dataPrep_LGG, dataPrep_GBM),
geneInfo = TCGAbiolinks::geneInfo,
method = "gcContent") #18323 672
dataFilt <- TCGAanalyze_Filtering(tabDF = dataNorm,
method = "quantile",
qnt.cut = 0.25) # 13742 672
save(dataFilt, file = paste0("LGG_GBM_Norm_IlluminaHiSeq.rda"))
dataFiltLGG <- subset(dataFilt, select = substr(colnames(dataFilt),1,12) %in% lgg_clin$bcr_patient_barcode)
dataFiltGBM <- subset(dataFilt, select = substr(colnames(dataFilt),1,12) %in% gbm_clin$bcr_patient_barcode)
dataDEGs <- TCGAanalyze_DEA(mat1 = dataFiltLGG,
mat2 = dataFiltGBM,
Cond1type = "LGG",
Cond2type = "GBM",
fdr.cut = 0.01 ,
logFC.cut = 1,
method = "glmLRT")# Number of differentially expressed genes (DEG)
nrow(dataDEGs)[1] 2535
4.3.2 EA: enrichment analysis
In order to understand the underlying biological process of DEGs we performed an enrichment analysis using TCGAanalyze_EA_complete function.
#------------------- 4.2 EA: enrichment analysis --------------------
ansEA <- TCGAanalyze_EAcomplete(TFname="DEA genes LGG Vs GBM", RegulonList = rownames(dataDEGs))
TCGAvisualize_EAbarplot(tf = rownames(ansEA$ResBP),
filename = NULL,
GOBPTab = ansEA$ResBP,
GOCCTab = ansEA$ResCC,
GOMFTab = ansEA$ResMF,
PathTab = ansEA$ResPat,
nRGTab = rownames(dataDEGs),
nBar = 20)
The plot shows canonical pathways significantly overrepresented (enriched) by the DEGs (differentially expressed genes) with the number of genes for the main categories of three ontologies (GO:biological process, GO:cellular component, and GO:molecular function, respectively). The most statistically significant canonical pathways identified in DEGs list are listed according to their p value corrected FDR (-Log) (colored bars) and the ratio of list genes found in each pathway over the total number of genes in that pathway (ratio, red line).]
TCGAanalyze_EAbarplot outputs a bar chart as shown in figure with the number of genes for the main categories of three ontologies (i.e., GO biological process, GO cellular component, and GO molecular function).
The Figure shows canonical pathways significantly overrepresented (enriched) by the DEGs. The most statistically significant canonical pathways identified in the DEGs are ranked according to their p-value corrected FDR (-Log10) (colored bars) and the ratio of list genes found in each pathway over the total number of genes in that pathway (ratio, red line).
4.3.3 PEA: Pathways enrichment analysis
To verify if the genes found have a specific role in a pathway, the Bioconductor package pathview (Luo and Brouwer 2013) can be used. Listing below shows an example how to use it. It can receive, for example, a named vector of gene with the expression level, the pathway.id which can be found in KEGG database, the species (’hsa’ for Homo sapiens) and the limits for the gene expression.
library(SummarizedExperiment)
GenelistComplete <- rownames(assay(lgg.exp,1))
# DEGs TopTable
dataDEGsFiltLevel <- TCGAanalyze_LevelTab(dataDEGs,"LGG","GBM",
dataFilt[,colnames(dataFiltLGG)],
dataFilt[,colnames(dataFiltGBM)])
dataDEGsFiltLevel$GeneID <- 0
library(clusterProfiler)
# Converting Gene symbol to geneID
eg = as.data.frame(bitr(dataDEGsFiltLevel$mRNA,
fromType="SYMBOL",
toType="ENTREZID",
OrgDb="org.Hs.eg.db"))
eg <- eg[!duplicated(eg$SYMBOL),]
dataDEGsFiltLevel <- dataDEGsFiltLevel[dataDEGsFiltLevel$mRNA %in% eg$SYMBOL,]
dataDEGsFiltLevel <- dataDEGsFiltLevel[order(dataDEGsFiltLevel$mRNA,decreasing=FALSE),]
eg <- eg[order(eg$SYMBOL,decreasing=FALSE),]
# table(eg$SYMBOL == dataDEGsFiltLevel$mRNA) should be TRUE
all(eg$SYMBOL == dataDEGsFiltLevel$mRNA)[1] TRUE
dataDEGsFiltLevel$GeneID <- eg$ENTREZID
dataDEGsFiltLevel_sub <- subset(dataDEGsFiltLevel, select = c("GeneID", "logFC"))
genelistDEGs <- as.numeric(dataDEGsFiltLevel_sub$logFC)
names(genelistDEGs) <- dataDEGsFiltLevel_sub$GeneIDlibrary(pathview)
# pathway.id: hsa05214 is the glioma pathway
# limit: sets the limit for gene expression legend and color
hsa05214 <- pathview::pathview(
gene.data = genelistDEGs,
pathway.id = "hsa05214",
species = "hsa",
limit = list(gene=as.integer(max(abs(genelistDEGs)))))The red genes are up-regulated and the green genes are down-regulated in the LGG samples compared to GBM.
Pathways enrichment analysis : glioma pathway. Red defines genes that are up-regulated and green defines genes that are down-regulated.
4.3.4 Inference of gene regulatory networks
Starting with the set of differentially expressed genes, we infer gene regulatory networks using the following state-of-the art inference algorithms: ARACNE (Margolin et al. 2006), CLR (Faith et al. 2007), MRNET (Meyer et al. 2007) and C3NET (Altay and Emmert-Streib 2010). These methods are based on mutual inference and use different heuristics to infer the edges in the network. These methods have been made available via Bioconductor/CRAN packages (MINET (Meyer, Lafitte, and Bontempi 2008) and c3net, (Altay and Emmert-Streib 2010) respectively). Many gene regulatory interactions have been experimentally validated and published. These ’known’ interactions can be accessed using different tools and databases such as BioGrid (Stark et al. 2006) or GeneMANIA (Montojo et al. 2010). However, this knowledge is far from complete and in most cases only contains a small subset of the real interactome. The quality assessment of the inferred networks can be carried out by comparing the inferred interactions to those that have been validated. This comparison results in a confusion matrix as presented in Table below.
| validated | not validated/non-existing | |
|---|---|---|
| inferred | TP | FP |
| not inferred | FN | TN |
Different quality measures can then be computed such as the false positive rate \[fpr=\frac{FP}{FP+TN},\] the true positive rate (also called recall) \[tpr=\frac{TP}{TP+FN}\] and the precision \[p=\frac{TP}{TP+FP}.\] The performance of an algorithm can then be summarized using ROC (false positive rate versus true positive rate) or PR (precision versus recall) curves.
A weakness of this type of comparison is that an edge that is not present in the set of known interactions can either mean that an experimental validation has been tried and did not show any regulatory mechanism or (more likely) has not yet been attempted.
In the following, we ran the nce on i) the 2,901 differentially expressed genes identified in Section “Transcriptomic analysis”.
Retrieving known interactions
We obtained a set of known interactions from the BioGrid database.
There are 3,941 unique interactions between the 2,901 differentially expressed genes.
Using differentially expressed genes from TCGAbiolinks workflow
We start this analysis by inferring one gene set for the LGG data.
### read biogrid info (available in TCGAWorkflowData as "biogrid")
### Check last version in https://thebiogrid.org/download.php
file <- "http://thebiogrid.org/downloads/archives/Release%20Archive/BIOGRID-3.4.146/BIOGRID-ALL-3.4.146.tab2.zip"
if(!file.exists(gsub("zip","txt",basename(file)))){
downloader::download(file,basename(file))
unzip(basename(file),junkpaths =TRUE)
}
tmp.biogrid <- read.csv(gsub("zip","txt",basename(file)), header=TRUE, sep="\t", stringsAsFactors=FALSE)### plot details (colors & symbols)
mycols <- c('#e41a1c','#377eb8','#4daf4a','#984ea3','#ff7f00','#ffff33','#a65628')
### load network inference libraries
library(minet)
library(c3net)
### deferentially identified genes using TCGAbiolinks
# we will use only a subset (first 50 genes) of it to make the example faster
names.genes.de <- rownames(dataDEGs)[1:30]
data(biogrid)
net.biogrid.de <- getAdjacencyBiogrid(tmp.biogrid, names.genes.de)
mydata <- dataFiltLGG[names.genes.de, ]
### infer networks
t.mydata <- t(mydata)
net.aracne <- minet(t.mydata, method = "aracne")
net.mrnet <- minet(t.mydata)
net.clr <- minet(t.mydata, method = "clr")
net.c3net <- c3net(mydata)
### validate compared to biogrid network
tmp.val <- list(validate(net.aracne, net.biogrid.de),
validate(net.mrnet, net.biogrid.de),
validate(net.clr, net.biogrid.de),
validate(net.c3net, net.biogrid.de))
### plot roc and compute auc for the different networks
dev1 <- show.roc(tmp.val[[1]],cex=0.3,col=mycols[1],type="l")
res.auc <- auc.roc(tmp.val[[1]])
for(count in 2:length(tmp.val)){
show.roc(tmp.val[[count]],device=dev1,cex=0.3,col=mycols[count],type="l")
res.auc <- c(res.auc, auc.roc(tmp.val[[count]]))
}
legend("bottomright", legend=paste(c("aracne","mrnet","clr","c3net"), signif(res.auc,4), sep=": "),
col=mycols[1:length(tmp.val)],lty=1, bty="n" )
# Please, uncomment this line to produce the pdf files.
# dev.copy2pdf(width=8,height=8,device = dev1, file = paste0("roc_biogrid_",cancertype,".pdf"))
ROC with corresponding AUC for inferred GBM networks compared to BioGrid interactions
In Figure above, the obtained ROC curve and the corresponding area under curve (AUC) are presented. It can be observed that CLR and MRNET perform best when comparing the inferred network with known interactions from the BioGrid database.
4.4 Epigenetic analysis
The DNA methylation is an important component in numerous cellular processes, such as embryonic development, genomic imprinting, X-chromosome inactivation, and preservation of chromosome stability (Phillips 2008).
In mammals DNA methylation is found sparsely but globally, distributed in definite CpG sequences throughout the entire genome; however, there is an exception. CpG islands (CGIs) which are short interspersed DNA sequences that are enriched for GC. These islands are normally found in sites of transcription initiation and their methylation can lead to gene silencing (Deaton and Bird 2011).
Thus, the investigation of the DNA methylation is crucial to understanding regulatory gene networks in cancer as the DNA methylation represses transcription (Robertson 2005). Therefore, the DMR (Differentially Methylation Region) detection can help us investigate regulatory gene networks.
This section describes the analysis of DNA methylation using the Bioconductor package TCGAbiolinks (Colaprico et al. 2016). For this analysis, and due to the time required to perform it, we selected only 10 LGG samples and 10 GBM samples that have both DNA methylation data from Infinium HumanMethylation450 and gene expression from Illumina HiSeq 2000 RNA Sequencing Version 2 analysis (lines 1-56 of the listing below describes how to make the data acquisition). We started by checking the mean DNA methylation of different groups of samples, then performed a DMR in which we search for regions of possible biological significance, (e.g., regions that are methylated in one group and unmethylated in the other). After finding these regions, they can be visualized using heatmaps.
4.4.1 Visualizing the mean DNA methylation of each patient
It should be highlighted that some pre-processing of the DNA methylation data was done. The DNA methylation data from the 450k platform has three types of probes cg (CpG loci) , ch (non-CpG loci) and rs (SNP assay). The last type of probe can be used for sample identification and tracking and should be excluded for differential methylation analysis according to the ilumina manual. Therefore, the rs probes were removed (see listing below lines 68). Also, probes in chromosomes X, Y were removed to eliminate potential artifacts originating from the presence of a different proportion of males and females (Marabita et al. 2013). The last pre-processing steps were to remove probes with at least one NA value (see listing below lines 65).
After this pre-processing step and using the function TCGAvisualize_meanMethylation function, we can look at the mean DNA methylation of each patient in each group. It receives as argument a SummarizedExperiment object with the DNA methylation data, and the arguments groupCol and subgroupCol which should be two columns from the sample information matrix of the SummarizedExperiment object (accessed by the colData function) (see listing below lines 70-74).
#----------------------------
# Obtaining DNA methylation
#----------------------------
# Samples
lgg.samples <- matchedMetExp("TCGA-LGG", n = 10)
gbm.samples <- matchedMetExp("TCGA-GBM", n = 10)
samples <- c(lgg.samples,gbm.samples)
#-----------------------------------
# 1 - Methylation
# ----------------------------------
# For methylation it is quicker in this case to download the tar.gz file
# and get the samples we want instead of downloading files by files
query <- GDCquery(project = c("TCGA-LGG","TCGA-GBM"),
data.category = "DNA methylation",
platform = "Illumina Human Methylation 450",
legacy = TRUE,
barcode = samples)
GDCdownload(query)
met <- GDCprepare(query, save = FALSE)
# We will use only chr9 to make the example faster
met <- subset(met,subset = as.character(seqnames(met)) %in% c("chr9"))
# This data is avaliable in the package
save(met, file = "met20SamplesGBMLGGchr9.rda")data(met20SamplesGBMLGGchr9)
#----------------------------
# Mean methylation
#----------------------------
# Plot a barplot for the groups in the disease column in the
# summarizedExperiment object
# remove probes with NA (similar to na.omit)
met <- subset(met,subset = (rowSums(is.na(assay(met))) == 0))
TCGAvisualize_meanMethylation(met,
groupCol = "disease_type",
group.legend = "Groups",
filename = NULL,
print.pvalue = TRUE)## groups Mean Median Max Min
## 1 Brain Lower Grade Glioma 0.5159918 0.5320007 0.5610239 0.4509977
## 2 Glioblastoma Multiforme 0.4600086 0.4780980 0.5186596 0.3060219
## Brain Lower Grade Glioma Glioblastoma Multiforme
## Brain Lower Grade Glioma NA 0.02181625
## Glioblastoma Multiforme 0.02181625 NA
The figure above illustrates a mean DNA methylation plot for each sample in the GBM group (140 samples) and a mean DNA methylation for each sample in the LGG group. Genome-wide view of the data highlights a difference between the groups of tumors.
4.4.2 Searching for differentially methylated CpG sites
The next step is to define differentially methylated CpG sites between the two groups. This can be done using the TCGAanalyze_DMR function (see listing below). The DNA methylation data (level 3) is presented in the form of beta-values that uses a scale ranging from 0.0 (probes completely unmethylated ) up to 1.0 (probes completely methylated).
To find these differentially methylated CpG sites, first, the function calculates the difference between the mean DNA methylation (mean of the beta-values) of each group for each probe. Second, it test for differential expression between two groups using the wilcoxon test adjusting by the Benjamini-Hochberg method. Arguments of TCGAanalyze_DMR was set to require a minimum absolute beta-values difference of 0.15 and an adjusted p-value of less than \(0.05\).
After these tests, a volcano plot (x-axis: difference of mean DNA methylation, y-axis: statistical significance) is created to help users identify the differentially methylated CpG sites and return the object with the results in the rowRanges.
#------- Searching for differentially methylated CpG sites ----------
met <- TCGAanalyze_DMR(met,
groupCol = "disease_type", # a column in the colData matrix
group1 = "Glioblastoma Multiforme", # a type of the disease type column
group2 = "Brain Lower Grade Glioma", # a type of the disease column
p.cut = 0.05,
diffmean.cut = 0.15,
save = FALSE,
legend = "State",
plot.filename = "LGG_GBM_metvolcano.png",
cores = 1
)Figure below shows the volcano plot produced by listing below. This plot aids the user in selecting relevant thresholds, as we search for candidate biological DMRs.